<SEC-DOCUMENT>0001683168-25-001349.txt : 20250305
<SEC-HEADER>0001683168-25-001349.hdr.sgml : 20250305
<ACCEPTANCE-DATETIME>20250305151126
ACCESSION NUMBER:		0001683168-25-001349
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250227
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250305
DATE AS OF CHANGE:		20250305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		25710494

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:RDNT="http://radnet.com/20250227">
<head>
     <title>RadNet, Inc. 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_RDNT_radnet.com_20250227 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250227_20250227 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000004" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20250227.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-02-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-27</xbrli:startDate>
        <xbrli:endDate>2025-02-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM
<span id="xdx_90B_edei--DocumentType_c20250227__20250227_zQrFikoi5R7l"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported) <b><span id="xdx_907_edei--DocumentPeriodEndDate_c20250227__20250227_zCs8MhnLauzl"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February
27, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_909_edei--EntityRegistrantName_c20250227__20250227_z1UkCTCNH0k9" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000011" name="dei:EntityRegistrantName">RadNet,
Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250227__20250227_zV3qCzQMY6ac" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><span id="xdx_908_edei--EntityFileNumber_c20250227__20250227_zSr2SrVWXtw9" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000013" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20250227__20250227_zHLwAXdyK1o" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000014" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(State or other jurisdiction<br/>
    of incorporation)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; width: 49%"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20250227__20250227_ze2fhtwczoV8"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000015" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></b></td>
  <td style="width: 2%">&#160;</td>
  <td style="text-align: center; width: 49%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1pt solid; text-align: center"><b><span id="xdx_90F_edei--EntityAddressCityOrTown_c20250227__20250227_zmaX3Gftmbuf"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000016" name="dei:EntityAddressCityOrTown">Los
  Angeles</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250227__20250227_zYqDgd9jappg"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: center"><b><span id="xdx_909_edei--EntityAddressPostalZipCode_c20250227__20250227_zOM9Xk4Lslk5"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000018" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center">(Address of Principal Executive Offices)</td>
  <td>&#160;</td>
  <td style="text-align: center">(Zip Code)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Registrant&#8217;s
Telephone Number, Including Area Code: <b>(<span id="xdx_90A_edei--CityAreaCode_c20250227__20250227_z12tjYfGOhx5"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000019" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20250227__20250227_zAqdExZwtQB5"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000020" name="dei:LocalPhoneNumber">445-2800</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"/><td style="width: 21.5pt"><span id="xdx_908_edei--WrittenCommunications_c20250227__20250227_zDXrazD057gc" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"/><td style="width: 21.5pt"><span id="xdx_903_edei--SolicitingMaterial_c20250227__20250227_zKX7SeUL5ct7" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"/><td style="width: 21.5pt"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20250227__20250227_zTzU7bDGqkTd" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"/><td style="width: 21.5pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20250227__20250227_zSgnL7fJeDz8" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 35%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
                                            of each class</b></span></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_902_edei--Security12bTitle_c20250227__20250227_zhyMwQ7LxFl4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000025" name="dei:Security12bTitle">Common
    Stock, $0.0001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_900_edei--TradingSymbol_c20250227__20250227_z8XjjVoKDwcl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-02-27" id="Fact000026" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20250227__20250227_zWwQ69D2AS4d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20250227__20250227_zpo6M3YEJrU5"><ix:nonNumeric contextRef="AsOf2025-02-27" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">Item 2.02</td><td>RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 27, 2025 RadNet,
Inc. (&#8220;RadNet&#8221;) issued a press release and, on February 28, 2025, held a conference call regarding its 2024 financial results
for the fourth quarter and full fiscal year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 and a copy
of the transcript of the conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Current
Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report,
including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement or other document filed
with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 9.01</b></td><td style="text-align: justify"><b>FINANCIAL STATEMENTS AND EXHIBITS.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 12%"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Exhibit No.</span></b></span></td>
    <td style="width: 88%"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>


<tr style="vertical-align: top">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td><span style="font-size: 10pt"></span>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-weight: normal"><a href="radnet_ex9901.htm">Press Release dated February 27, 2025 relating to RadNet, Inc.&#8217;s financial results for the quarter and full fiscal year ended December 31, 2024.</a></span></p>
<span style="font-size: 10pt"></span></td></tr>
  <tr style="vertical-align: top">
    <td>99.2</td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-weight: normal"><a href="radnet_ex9902.htm">Transcript of conference call.</a></span></p>
</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 99.1pt 0 98.85pt; text-align: center; background-color: white"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 5, 2025</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RADNET, INC.</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 53%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 41%; text-align: center">&#160;</td>
    <td style="width: 2%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mark  Stolper</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark  Stolper</span></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer </span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 12%"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Exhibit No.</span></b></span></td>
    <td style="width: 88%"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>


<tr style="vertical-align: top">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td><span style="font-size: 10pt"></span>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-weight: normal"><a href="radnet_ex9901.htm">Press Release dated February 27, 2025 relating to RadNet, Inc.&#8217;s financial results for the quarter and full fiscal year ended December 31, 2024.</a></span></p>
<span style="font-size: 10pt"></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>99.2</td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-weight: normal"><a href="radnet_ex9902.htm">Transcript of conference call.</a></span></p>
</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fm2igvZNi4pYRYqIr8FuJdhmyyb+HclbGlvEZWFZZr4ZIXpiRUtTIcNpnmdwwLqptEfIsURGe8bgSNebBMLN8WKcZ219+/7AlAKDgRn3ldJBaK1347BIIB4N5GSgRiBlMpzCbCuir56SLU2B1htdgbYF7JkaNug1v7qEg36SpfrVVh2RnSGbgOzHnfwGFUsFO7rrB/HVQZalIuq1E4kV060JrsXTo/2SsKiwDnWuo/8bfQABzEqE -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 104px; width: 200px"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 14pt"><B>RadNet Reports Fourth Quarter 2024
Results, Including Record Revenue and Adjusted EBITDA<SUP>(1)</SUP> and Releases 2025 Financial Guidance</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Total Company Revenue increased 13.5% to a quarterly record of $477.1
million in the fourth quarter of 2024 from $420.4 million in the fourth quarter of 2023; Revenue from the Digital Health reportable segment
(inclusive of intersegment revenue) increased 28.1% to $18.9 million in the fourth quarter of 2024 from $14.7 million in the fourth quarter
of 2023</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Total Company Adjusted EBITDA<SUP>(1) </SUP>was a quarterly record of
$75.0 million in the fourth quarter of 2024 as compared with $65.8 million in the fourth quarter of 2023, an increase of 14.0%; Digital
Health reportable segment Adjusted EBITDA<SUP>(1)</SUP> increased 61.6% to $4.5 million in the fourth quarter of 2024 from $2.8 million
in the fourth quarter of 2023</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusting for unusual or one-time items impacting Net Income in the quarter,
Adjusted Earnings Per Share<SUP>(3) </SUP>was $0.22 for the fourth quarter of 2024; This compares with Adjusted Earnings Per Share<SUP>(3)</SUP>
of $0.15 for the fourth quarter of 2023 </I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>In the fourth quarter of 2024, aggregate procedural volumes increased
8.0% and same-center procedural volumes increased 4.0% compared with the fourth quarter of 2023</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>At December 31, 2024, RadNet had a cash balance of $740 million and a
net debt to Adjusted EBITDA<SUP>(1)</SUP> leverage ratio of under 1.0x</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, February 27, 2024
&ndash; RadNet, Inc. (NASDAQ: RDNT),</B> a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic
imaging services through a network of 398 owned and/or operated outpatient imaging centers, today reported financial results for its fourth
quarter and full-year ended December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented, &ldquo;I am very pleased with our performance in the fourth quarter and for full-year 2024. Relative to
last year&rsquo;s fourth quarter, Revenue increased 13.5% and Adjusted EBITDA<SUP>(1)</SUP> increased 14.0%. This performance was driven
by strong aggregate procedural volume growth of 8.0% and same center procedural growth of 4.0%. This performance enabled us to meet or
exceed guidance levels we set at the beginning of 2024 and revised upward throughout the year.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;During the fourth
quarter, we continued to experience increased demand in virtually all of our markets. This demand was the primary catalyst for the investments
made to expand capacity by the opening of nine new centers during the year. Throughout 2024, the centers within health system partnerships
grew from 130 at the beginning of 2024 to 153 by the end of the year. Joint venture facilities now represent 38.4% of the 398 locations.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;During 2024, significant progress was made
in the Digital Health division, culminating with the fourth quarter launch of DeepHealth OS, SmartMammo<SUP>TM</SUP> and TechLive<SUP>TM</SUP>
solutions in addition to expansion of the AI clinical tools in breast, lung, prostate and brain. We intend to implement these new solutions
throughout the RadNet network during 2025, and they should create significant efficiencies in our operations that will help address challenges
resulting from the shortage and rising cost of skilled labor. Furthermore, these solutions will enable us to expand capacity by streamlining
workflow and automating processes that will improve the patient experience,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;During 2024, liquidity and financial leverage
were carefully managed, as highlighted by a $230 million stock offering completed in March, a debt refinancing completed in April which
lowered our cost of capital and extended maturities through 2031 and a debt repricing transaction completed in November which lowered
the interest cost on RadNet&rsquo;s credit facility. As a result of these actions and a focus on margins and Adjusted EBITDA<SUP>(1)</SUP>
growth, at year-end 2024, net debt to Adjusted EBITDA<SUP>(1)</SUP> fell below 1.0x, from approximately 2.0x at year-end 2023. The cash
balance at the end of 2024 grew to $740 million, from $342 million at year-end 2023,&rdquo; concluded Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fourth Quarter Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2024, RadNet reported
Total Company Revenue of $477.1 million and Adjusted EBITDA<SUP>(1)</SUP> of $75.0 million. Revenue increased $56.7 million (or 13.5%)
and Adjusted EBITDA<SUP>(1)</SUP> increased $9.2 million (or 14.0%) as compared with the fourth quarter of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2024, RadNet reported
Digital Health Revenue of $18.9 million (inclusive of intersegment revenue) and Adjusted EBITDA<SUP>(1)</SUP> of $4.5 million. Revenue
increased $4.1 million (or 28.1%) and Adjusted EBITDA<SUP>(1)</SUP> increased $1.7 million (or 61.6%) as compared with the fourth quarter
of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual or one-time items
impacting the fourth quarter including: $1.1 million in severance expense related to cost-savings initiatives; $2.5 million impairment
loss on lease abandonment; $1.1 million expense related to leases for de novo facilities under construction that have yet to open their
operations; $462,000 of acquisition transaction costs; $2.4 million loss in conjunction with extinguishment of debt and related expenses
as a result of the Company&rsquo;s refinancing and repricing debt transactions; $5.0 million of non-capitalized research and development
expenses related to the DeepHealth Cloud OS and generative AI; and $577,000 of non-cash loss from interest rate swaps. Adjusting for the
above items, Total Company Adjusted Earnings<SUP>(3)</SUP> was $16.7 million and diluted Adjusted Earnings Per Share<SUP>(3)</SUP> was
$0.22 during the fourth quarter of 2024. This compares with Total Company Adjusted Earnings<SUP>(3)</SUP> of $9.9 million and diluted
Adjusted Earnings Per Share<SUP>(3)</SUP> of $0.15 during the fourth quarter of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unadjusted for unusual or one-time items impacting
the fourth quarter, Total Company Net Income for the fourth quarter of 2024 was $5.3 million as compared with a Total Company Net Loss
of $1.9 million for the fourth quarter of 2024. Fully diluted Net Income Per Share for the fourth quarter of 2024 was $0.07, compared
with a fully diluted Net Loss per share of $(0.03) in the fourth quarter of 2023, based upon a weighted average number of diluted shares
outstanding of 75.5 million shares in 2024 and 67.9 million shares in 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2024, as compared with
the prior year&rsquo;s fourth quarter, MRI volume increased 13.4%, CT volume increased 13.9% and PET/CT volume increased 23.9%. Overall
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 8.0% over the
prior year&rsquo;s fourth quarter. On a same-center basis, including only those centers which were part of RadNet for both the fourth
quarters of 2024 and 2023, MRI volume increased 8.5%, CT volume increased 8.7% and PET/CT volume increased 16.3%. Overall same-center
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 4.0% over the
prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Annual Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full-year 2024, RadNet reported Total Company
Revenue of $1,829.7 million and Adjusted EBITDA<SUP>(1)</SUP> of $279.5 million. Revenue increased $213.0 million (or 13.2%) and Adjusted
EBITDA<SUP>(1)</SUP> increased $47.1 million (or 20.3%) as compared with full-year 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full-year 2024, RadNet reported Digital Health
Revenue (inclusive of intersegment revenue) of $65.7 million and Adjusted EBITDA<SUP>(1)</SUP> of $14.6 million. Revenue increased $16.1
million (or 32.5%) and Adjusted EBITDA<SUP>(1)</SUP> increased $8.1 million (or 124.0%) as compared with full-year 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unadjusted for one-time or unusual items, Total
Company Net Income for 2024 was $2.8 million as compared with a Total Company Net Income of $3.0 million in 2023. Fully diluted Net Income
Per Share for 2024 was $0.04, compared with a Net Income per share of $0.05 in 2023, based upon a weighted average number of diluted shares
outstanding of 74.8 million shares in 2024 and 64.7 million shares in 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Actual 2024 Results vs. 2024 Guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Imaging Center Segment</U></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Original Guidance Range</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Revised Guidance Range After Q1 Results</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Revised Guidance Range After Q2 Results</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Revised Guidance Range After Q3 Results</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Actual 2024 Results</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 17%; text-align: left">Total Net Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">$1,650-$1,700mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">$1,675-$1,725mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">$1,685-$1,735mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">$1,710-$1,760mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: left">$1,764.0mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$250 - $260mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$255 - $265mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$257 - $267mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$262 - $270mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$264.9mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Capital Expenditures<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(a)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$125 - $135mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$130 - $140mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$135 - $145mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$145 - $155mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$148.1mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Cash Interest Expense<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(b)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$40 - $45mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$37 - $42mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$32 - $37mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$25 - $30mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$33.3mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Free Cash Flow <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$65 - $75mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$68 - $78mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$72 - $80mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$83 - $93mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$83.5mm</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment ($886,000), New Jersey Imaging Network capital expenditures
of $20.7mm and a one-time $6.6 million operating lease buyout from two equipment manufacturers.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">Includes payments to and from counterparties on interest rate swaps and nets interest income from our
cash balance as recorded in Other Income.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Digital Health Segment</U></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Original</P>
                                                                   <P STYLE="margin-top: 0; margin-bottom: 0">Guidance</P>
                                                                   <P STYLE="margin-top: 0; margin-bottom: 0">Range</P></TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Revised Guidance Range After</P>
                                                                   <P STYLE="margin-top: 0; margin-bottom: 0">Q1 and Q2 Results</P></TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Revised Guidance Range After</P>
                                                                   <P STYLE="margin-top: 0; margin-bottom: 0">Q3 Results</P></TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Actual</P>
                                                                   <P STYLE="margin-top: 0; margin-bottom: 0">2024 Results</P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 48%; font-weight: 400; font-style: normal; text-align: left">Total Net Revenue <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400">(inclusive of intersegment revenue)</FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: left">$60 - $70mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: left">$60 - $70mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: left">$60 - $70mm</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: left">$65.7mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP> Before Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$12 - $14mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$13 - $15mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$13 - $15mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$14.6mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$11 - $13mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$12 - $14mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$13 - $15mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$15.0mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Capital Expenditures<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(a)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$3 - $5mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$3 - $5mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$3 - $5mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$3.5mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Free Cash Flow<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP> Before Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$8 - $10mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$8 - $10mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$8 - $10mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$11.1mm</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Free Cash Flow<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP> After Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$(2) - $(5)mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$(2) - $(5)mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$(2) - $(5)mm</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$(3.9)mm</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Excludes a $9 million purchase of software code and other intellectual property from a vender.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2025 Guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger highlighted, &ldquo;In January and
February of 2025, we experienced more severe winter weather conditions than last year in our East Coast and Texas operations as well as
catastrophic fires in Southern California. These unanticipated events had a significant impact on the utilization of healthcare services
in these regions, which resulted in an estimated loss of $22 million of Revenue and $15 million of Adjusted EBITDA<SUP>(1) </SUP>to the
RadNet operations. These significant events have caused a revision to the first quarter of our initial 2025 Imaging Center segment budget,
which is now reflected in our full-year 2025 guidance.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet reports 2025 guidance ranges as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Imaging Center Segment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">2025</P>
                                                                           <P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">Guidance Range</P></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 76%; text-align: justify">Total Net Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: center">$1,825 - $1,875 million</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$265 - $273 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Capital Expenditures<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(a)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$140 - $150 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Cash Interest Expense<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(b)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$35 - $40 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Free Cash Flow<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$70 - $80 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment and New Jersey Imaging Network capital expenditures.</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>(b)</TD><TD STYLE="text-align: justify">Net of payments from counterparties on interest rate swaps and interest income from our cash balance recorded
in Other Income.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Digital Health Segment</U></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 76%">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left; width: 1%">&nbsp;</TD>
                                                                 <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 20%"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">2025</P>
                                                                           <P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">Guidance Range</P></TD><TD STYLE="padding-bottom: 1pt; text-align: left; width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Total Net Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$80 - $90 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP> Before Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$15 - $17 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$16 - $18 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Capital Expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$3 - $5 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Free Cash Flow<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP> Before Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$11 - $13 million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Free Cash Flow<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP> After Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">$(5) - $(8) million</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr Berger added, &ldquo;Within the Imaging Center
segment, 2025 performance will be impacted by continued focus on same-center performance, tuck-in acquisitions, increasing reimbursement
efforts, expanded and new health system joint ventures and de novo center openings. Incorporated into 2025 guidance is continued increases
in salaries, wages and benefits, which is indicative of broader industry conditions. To address the labor challenges, we will be focused
in 2025 on the implementation of the Digital Health solutions intended to drive automation and efficiencies in the utilization of labor.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Within the Digital Health segment, 2025
growth will be driven by a variety of factors including, sales of the new DeepHealth OS Operating and Diagnostic software suites, sales
and licensing revenue from the new SmartTechology<SUP>TM</SUP> products (eg, SmartMammo<SUP>TM</SUP>), licensing fees from the TechLive<SUP>TM</SUP>
technologist remote-control and automation technology and further licensing and patient revenue from mammography, lung, prostate and brain
AI solutions. In 2025, significant infrastructure investments will be made in building sales, marketing and implementation teams and we
will pursue completing potential acquisitions, both of which will contribute to the long-term success in selling and licensing Digital
Health solutions to external customers&rdquo;, concluded Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Tomorrow</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call tomorrow, February 28th,
at 10:30 a.m. Eastern Time. During the call, management will discuss the Company's 2024 fourth quarter and year-end results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Friday, February 28, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. ET</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 844-826-3035</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 412-317-5195</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">There will also be simultaneous and archived
webcasts available at </FONT>https://viavid.webcasts.com/starthere.jsp?ei=1708732&amp;tp_key=80b765a1d9
<FONT STYLE="font-size: 10pt">or http://www.radnet.com under the &ldquo;About RadNet&rdquo; menu section
and &ldquo;News &amp; Press Releases&rdquo; sub-menu of the website. An archived replay of the call will also be available and can be
accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10197109.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet, Inc. is the leading national provider of freestanding, fixed-site
diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based
on the number of locations and annual imaging revenue. RadNet has a network of 398 owned and/or operated outpatient imaging centers. RadNet's
markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas. Together with affiliated radiologists,
and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 employees. For more information,
visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking
statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and
strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified
by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo; &ldquo;seek,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;likely,&rdquo;
&ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references to future periods. Forward-looking statements in this
press release include, among others, statements we make regarding response to and the expected future impacts of COVID-19, including statements
about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to
service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are neither historical
facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and
financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue
reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions nationally
and regionally in the markets in which we operate, including their effects on the cost and availability of labor;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness, make
principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our
ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
the expansion of our business and improvements to our existing facilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit rating
and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates, or
credit markets;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings to
fund our current and future operations;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and procedure
volumes; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services provided;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner physicians
or joint venture partners;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment and related
developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act;
</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators or
related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor costs
and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in
our facilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political instability
or catastrophic events; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects related
to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or security
laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized
use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained in this
current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of
changed circumstances, new information, future developments or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes
that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes
this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in
the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should
not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled
measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this
release in the tables which follow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS:</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief Financial
Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2024</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2023</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Cash and Cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">740,020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">342,570</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">185,821</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,707</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,342</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">51,542</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">47,657</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,019,252</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">579,276</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">694,791</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">604,401</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">639,740</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">596,032</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left">Total property, plant, equipment and right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,334,531</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200,433</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">710,663</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">679,463</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,351</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,615</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,265</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,643</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,057</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92,710</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">34,571</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">46,333</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,286,690</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,690,473</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">351,464</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">342,940</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,910</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,288</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,647</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,618</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,981</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Current portion of notes payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">24,692</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,974</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">479,712</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">437,452</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Long-term operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">655,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">605,097</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">991,574</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">812,068</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred tax liability, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,230</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,776</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,785</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,721</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,153,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,877,114</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">RadNet, Inc. stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Common stock - $0.0001 value, 200,000,000 shares authorized; 74,036,993 and 67,956,318 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">988,147</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">722,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,061</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,484</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(76,785</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(79,578</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left">Total RadNet, Inc.'s Stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">902,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">630,695</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">231,102</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">182,664</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total Equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,133,410</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">813,359</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,286,690</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,690,473</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Years Ended December 31,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">REVENUE</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 55%; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,693,089</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,463,197</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,278,016</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">136,575</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">153,433</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">152,045</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total service revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,829,664</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,616,630</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,430,061</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,580,549</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,395,239</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,264,346</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Lease abandonment charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,146</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">128,391</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">115,877</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss (gain) on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,187</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,529</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss (gain) on contribution of imaging centers into joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,808</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,902</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,778</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">946</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,725,043</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,517,933</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,383,698</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) FROM OPERATIONS</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">104,621</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">98,697</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">46,363</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,849</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,483</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,841</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,472</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,427</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,390</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,006</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,185</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(39,621</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Debt restructuring and extinguishment expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,292</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">731</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expenses (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(24,916</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,354</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,833</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other (income) expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">59,759</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">59,887</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,394</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">44,862</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">38,810</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">42,969</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,026</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,473</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(9,361</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME (LOSS)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">38,836</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">30,337</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">33,608</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net income (loss) attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,043</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">27,293</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">22,958</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,793</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,044</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">10,650</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.04</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.05</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.19</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.04</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.05</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.17</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">73,037,237</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">63,580,059</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">56,293,336</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">74,762,332</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,658,299</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">57,320,870</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Years Ended December 31,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 55%; text-align: left">Net income (loss)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">38,836</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">30,337</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">33,608</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Adjustments to reconcile net income to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">128,391</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">115,877</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization of operating lease assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,552</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,102</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,847</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures, net of dividend</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,926</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,176</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,952</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,093</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,987</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,693</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,187</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,529</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on extinguishment of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,903</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Gain on contribution of imaging centers into joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,808</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Lease abandonment charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,146</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization of cash flow hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,352</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,576</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,687</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,006</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,185</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(39,621</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,833</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,785</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,770</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,275</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,995</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,880</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(325</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,767</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,078</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,790</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,441</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,327</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,723</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,484</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,166</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,454</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,056</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,356</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(54,866</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(54,763</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(68,943</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,359</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">626</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,316</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">37,117</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">15,086</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49,778</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,023</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">220,863</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">146,417</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Purchase of imaging facilities and other acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,661</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,918</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(129,961</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(188,070</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(176,600</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(119,451</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,904</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Equity contributions in existing and purchase of interest in joint ventures</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,496</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(14,035</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,441</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(233,070</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(201,470</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(246,949</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,989</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,930</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Payments on Term Loan Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(692,437</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(41,063</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(53,750</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from issuance of new debt, net of issuance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">863,757</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,996</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Sale of noncontrolling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,121</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Payments on contingent consideration and holdbacks</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,268</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,495</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Distributions paid to noncontrolling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,522</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,972</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(893</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from issuance of common stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">218,385</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,832</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">667</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">142</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">294</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">397,950</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">195,635</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">93,647</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(453</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(292</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">397,450</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">214,736</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,772</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">342,570</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">127,834</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">134,606</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">740,020</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">342,570</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">127,834</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">84,601</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,695</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">39,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Cash paid during the period for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,587</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">587</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR STYLE="clear: both">
</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended December 31,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">REVENUE</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">445,576</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">384,932</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,525</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">35,451</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total service revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">477,101</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">420,383</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">411,436</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">356,592</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Lease abandonment charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,146</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,016</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,686</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss (gain) on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,541</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,004</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,105</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">621</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">452,576</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">396,049</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) FROM OPERATIONS</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">24,525</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">24,334</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,073</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,607</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,164</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,492</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">577</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,236</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Debt restructuring and extinguishment expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expenses (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,668</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,745</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other (income) expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,201</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,606</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">15,324</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">6,728</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,099</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(732</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME (LOSS)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">14,225</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">5,996</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net income (loss) attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,880</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,856</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,345</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,860</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.07</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">0.07</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">73,574,262</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">67,904,999</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">75,537,595</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">67,904,999</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR STYLE="clear: both">
</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Three
    Months Ended December 31,</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Years
    Ended December 31,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">2024</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">2023</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">2024</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">2023</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; width: 40%; text-align: left"><FONT STYLE="font-size: 9pt">Net income (loss) attributable to Radnet, Inc. common stockholders</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 9pt">5,345</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 9pt">(1,860</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 9pt">2,793</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 9pt">3,044</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Income taxes</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,099</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">732</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">6,026</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">8,473</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Interest expense</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">18,073</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">16,607</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">79,849</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">64,483</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Severance costs</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,105</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">621</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,902</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,778</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Depreciation and amortization</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">36,016</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">32,686</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">137,838</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">128,391</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Non-cash employee stock-based compensation</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">8,465</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">5,404</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">29,834</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">26,785</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Loss (gain) on sale and disposal of equipment and other</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,541</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,276</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,187</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Non-cash change in fair value of interest rate hedge</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">577</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,236</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">8,006</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">8,185</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Other expenses (income)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(8,668</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(3,745</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(24,916</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(6,354</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">5,018</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">14,995</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Lease abandonment charges</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,478</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">5,146</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,478</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">5,146</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Loss (gain) on contribution of imaging centers into joint venture</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(16,808</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Loss (gain) on extinguishment of debt and related expenses</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,383</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">11,292</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Non-cash change to contingent consideration</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(429</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,974</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(4,075</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Acquisition related non-cash intangible adjustment</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Non-operational rent expenses</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,114</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">881</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4,233</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,629</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">Acquisition transaction costs</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">462</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">222</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">879</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">222</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Adjusted EBITDA - Radnet, Inc.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">75,008</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">65,813</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">279,459</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">232,344</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-decoration: underline; text-align: left"><FONT STYLE="font-size: 9pt">NOTE</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Adjusted EBITDA - Imaging Center Segment</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">70,468</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">63,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">264,901</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">225,846</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Adjusted EBITDA - Digital Health Segment</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4,540</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,809</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">14,558</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">6,498</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE <FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center">Three Months Ended</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023(iv)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; text-align: right">5,345</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; text-align: right">(1,858</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Add severance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,105</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">621</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Add loss on lease abandonment/impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,146</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Add non-operational rent expenses (i)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,114</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">880</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Add acquisition transaction costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">222</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Add loss on extinguishment of debt and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Add valuation adjustment for contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(429</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Add Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,308</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Add/Subtract non-cash change in fair value of swap valuation (ii)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">577</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,236</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total adjustments - loss (gain)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,137</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,984</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Subtract tax impact of Adjustments (iii)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,766</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,271</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,371</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,713</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">ADJUSTED NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,716</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,855</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,537,595</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,904,999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">ADJUSTED DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET,
    INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.22</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.15</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 97%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">(i) Represents rent expense associated with de novo sites under construction prior to them becoming operational.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">(ii) Impact from the change in fair value of the swaps during the quarter. Excludes the amortization of the accumulation of the
    changes in fair value out of Other Comprehensive Income that existed prior to the hedges becoming ineffective.</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">(iii) Tax effected using 13.44% and 21.83% blended federal and state effective tax rate for 2024 and 2023, respectively.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">(iv) Restated from what was presented in 2023 to include $4,973 of losses of the AI businesses (ie, this loss is
    not being added to earnings in the above as was the case in 2023). The restated Adjusted Earnings for 2023 is due to the
    fact that AI is no longer its own reportable operating segment and is now embedded in the Digital Health reportable operating segment.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYMENTS BY PAYOR CLASS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Fourth Quarter</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2024</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 34%; text-align: left">Commercial Insurance</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: right">58.0%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">23.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2.2%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other*</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">7.2%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100.0%</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-left: 244px; text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">* Includes management fee and Digital Health financial reporting unit revenue. </P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS BY MODALITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Fourth Quarter</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Full Year</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Full Year</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Full Year</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">2024</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">2024</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">2023</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 42%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">36.9%</TD><TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">37.1%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">36.8%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">36.8%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">15.7%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">15.9%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">16.8%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">17.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.6%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.2%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.4%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">5.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">5.7%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.0%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.5%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.7%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">13.5%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">13.6%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">12.9%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">12.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">16.9%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">16.4%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">16.0%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">15.3%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">0.9%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1.0%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">0.8%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">0.9%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">2.8%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">2.7%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">3.9%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.5%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100.0%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100.0%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100.0%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100.0%</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PROCEDURES BY MODALITY*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Fourth Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Fourth Quarter</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">2024</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">2023</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 30%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: right">452,063</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 13%">398,625</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">271,061</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,937</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">19,602</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">15,825</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9,054</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">8,120</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">655,531</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">617,301</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">517,013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">483,687</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">X-ray and Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">847,429</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">804,225</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 20pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,771,753</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,565,720</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-left: 196px; text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">* Volumes include wholly owned and joint venture centers.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> The Company defines Adjusted EBITDA
as earnings before interest, taxes, depreciation and amortization, each from continuing operations and excludes losses or gains on the
disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity compensation. Adjusted
EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries,
and is adjusted for non-cash and extraordinary events which took place during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest comparable
GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare
industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not
be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a
measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented,
may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(2)</SUP> As noted above, the Company defines
Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid. Free
Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information
for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not
represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition
of Free Cash Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives
to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the
consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined
in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable
to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(3)</SUP> The Company defines Adjusted Earnings
Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal of equipment,
loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation, gain on extinguishment
of debt, unusual or non-recurring entries that impact the Company&rsquo;s tax provision, pre-tax loss or gain from AI segment and any
other non-recurring or unusual transactions recorded during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Earnings Per Share is reconciled to its
nearest comparable GAAP financial measure (see table on prior page). Adjusted Earnings Per Share is a non-GAAP financial measure used
as analytical indicator by RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should
not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not be
considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other
financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As
Adjusted Earnings Per Share is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of
calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit 99.2</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="image_004.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR STYLE="clear: both">
&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #00339A"><B>C
O R P O R A T E P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger, </B><I>President, Chief Executive Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper, </B><I>Chief Financial Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #00339A"><B>C
O N F E R E N C E C A L L P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>David
MacDonald, </B><I>Truist Securities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut, </B><I>Jefferies</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom, </B><I>Raymond James</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Andrew
Mok, </B><I>Barclays</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Larry
Solow, </B><I>CJS Securities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Jim
Sidoti, </B><I>Sidoti &amp; Co.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #00339A"><B>P
R E S E N T A T I O N</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Good
day and welcome to the RadNet Inc. Fourth Quarter 2024 Financial Results Conference Call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">All
participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key
followed by zero. After today&rsquo;s presentation, there will be an opportunity to ask questions. To ask a question, you may press star
then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
would like to turn the conference over to Mark Stolper, Executive Vice President and CFO of RadNet. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Good
morning ladies and gentlemen, and thank you for joining Dr. Howard Berger and me today to discuss RadNet&rsquo;s fourth quarter and full-year
2024 financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Before
we begin today, we'd like to remind everyone of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995.
This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995.
Specifically, statements concerning anticipated future financial and operating performance, RadNet&rsquo;s ability to continue to grow
the business by generating patient referrals and contracts with radiology practices, recruiting and retaining technologists, receiving
third-party reimbursement for diagnostic imaging services, successfully integrating acquired operations, generating revenue and Adjusted
EBITDA for the acquired operations as estimated, among others, are forward-looking statements within the meaning of the Safe Harbor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Forward-looking
statements are based on Management's current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s
actual results to differ materially from the statements contained herein. These risks and uncertainties include those risks set forth
in RadNet&rsquo;s reports filed with the SEC from time to time, including RadNet's Annual Report on Form 10-K for the year ended December
31, 2024, to be filed shortly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Undue
reliance should not be placed on forward-looking statements, especially guidance on future financial performance which speaks only as
of the date it is made. RadNet undertakes no obligation to update publicly any forward-looking statements to reflect new information,
events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">With
that, I'd like to turn the call over to Dr. Berger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you, Mark. Good morning, everyone, and thank you for joining us today.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">On
today's call, Mark and I plan to provide you with highlights from our fourth quarter and full-year 2024 results, give you more insight
into factors which affected this performance and discuss our future strategy. After our prepared remarks, we will open the call to your
questions. I'd like to thank all of you for your interest in our company and for dedicating a portion of your day to participate in our
conference call this morning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">With
that, let's begin. I am very pleased with the performance in the fourth quarter. It was the strongest quarter in the Company's history
with record revenue and Adjusted EBITDA. Total company revenue increased 13.5% to $477.1 million, and Adjusted EBITDA increased 14% from
last year's fourth quarter to $75 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Digital
Health revenues increased 28.1% to $18.9 million, and Digital Health's Adjusted EBITDA increased 61.6% to $4.5 million from last year's
fourth quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Imaging
center revenue was driven by increased demand in virtually all of our markets, benefiting from the growing utilization of diagnostic
imaging within healthcare as well as the continuing shift of procedural volumes away from the more expensive hospital alternatives to
ambulatory freestanding imaging centers. As a result, we experienced 8% aggregate and 4% same-center procedural volume growth in this
year's fourth quarter relative to last year's same quarter. Also contributing to the strong revenue performance was the positive impact
of improved reimbursement from commercial payers who recognize the important role we are playing as a lower-priced alternative to hospital-based
imaging.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Lastly,
revenue benefited from the continuing shift in modality mix towards advanced imaging&mdash;MRI, CT and PET CT&mdash;where revenue per
scan is substantially higher than with routine imaging. During the fourth quarter, advanced imaging represented 26.8% of RadNet's procedural
volume, an increase of 137 basis points from last year's same quarter. This is both a function of the overall industry trend of more
of the PET CT exams being ordered as a result of technology advances in these modalities, as well as the significant capital investment
we have made in the last few years in advanced imaging equipment for growth and replacement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Twenty
twenty-four was also a year of significant investment. During 2024, we opened nine de novo facilities in markets where there are patient
backlogs, where we require additional capacity or we currently lack access points to service identified patient populations. These centers
should be material contributors to long-term performance and growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
continue to grow the hospital and health system joint venture business. Currently, 153 of RadNet's 398 centers or 38.4% are held within
system partnerships. This is an increase of 23 centers from year-end 2023. Health systems continue to seek long-term strategies around
outpatient imaging and have recognized that cost-effective and efficient freestanding centers will continue to capture market share from
hospitals as payers and patients migrate their site of care towards lower-cost, high-quality solutions. Our hospital and health system
partners have been instrumental in increasing our procedural volumes with their physician medical group relationships.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Momentum
continues with initiatives inside the Digital Health segment. In the fourth quarter, we commercially launched the DeepHealth OS operational
and diagnostic software suites, announced partnerships with GE and Siemens to bundle with or embed smart technologies into mammography
and ultrasound equipment, and commercialize the TechLive remote scanning solution for MRI and other modalities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">During
2024, we also continued to build executive management capabilities within Digital Health, culminating with Kees Wesdorp joining as the
CEO of the Digital Health division in September of 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Throughout
2025, we will be focused on implementing these DeepHealth solutions within the RadNet network of centers, which is expected to drive
operational efficiencies in many of the business processes performed on behalf of the imaging centers, primarily through automation.
Furthermore, these technologies will help create capacity that will enable the imaging centers to service increasing demand for diagnostic
services. At the same time, we will be investing aggressively to build the necessary infrastructure within Digital Health to sell and
support external customers. Embedded in our 2025 Digital Health guidance is approximately $20 million of investment primarily directed
towards building sales, marketing, customer support and implementation capabilities requisite to support significant external growth
in the coming years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
continue to focus on strengthening the balance sheet by managing liquidity and financial leverage. At year-end 2024, RadNet's cash balance
was $740 million, and the net debt to Adjusted EBITDA leverage ratio was under 1x.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">During
2024, we consummated a $230 million stock offering in March, a debt refinancing transaction in April, which lowered our cost of capital
and extended maturities through 2031, and a debt repricing transaction in November, which further lowered the interest cost on RadNet's
credit facility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">At
this time, I'd like to turn the call back over to Mark to discuss some of the highlights of our fourth quarter and full 2024 performance,
as well as discuss our 2025 guidance. When he is finished, I will make some closing remarks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you, Howard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I'm
now going to briefly review our fourth quarter and full year 2024 performance and attempt to highlight what I believe to be some material
items. I will also give some further explanation of certain items in our financial statements, as well as provide some insights into
some of the metrics that drove our fourth quarter and full year 2024 performance. I will also provide 2025 financial guidance levels
which were released in last evening's financial results press release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
my discussion, I will use the term Adjusted EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings
before interest, taxes, depreciation and amortization and excludes losses or gains on the disposal of equipment, other income or loss,
loss on debt extinguishments and noncash equity compensation. Adjusted EBITDA includes equity and earnings of unconsolidated operations
and subtracts allocations of earnings to noncontrolling interest in subsidiaries and is adjusted for noncash or extraordinary and one-time
events taking place during the period. A full quantitative reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet,
Inc. common shareholders is included in our earnings release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">With
that said, I'd now like to review our fourth quarter and full year 2024 results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
many of you may have seen in the financial results press release we made last night, we had a very strong fourth quarter. While I won't
recap all the financial information that's contained in yesterday's earnings report, here are some highlights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Fourth
quarter total Company revenue and Adjusted EBITDA were quarterly records. Revenue increased 13.5% and Adjusted EBITDA increased 14% from
last year's fourth quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Digital Health segment also exhibited strong growth in the quarter with revenue growing 28.1% and Adjusted EBITDA growing 61.6% from
last year's fourth quarter. Fourth quarter adjusted earnings per share for RadNet grew to $0.22 per share versus $0.15 per share for
last year's fourth quarter. Eight percent aggregate and 4% same-center procedure volume growth drove much of the top line performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Also
benefiting the fourth quarter was the continuing shift in business mix in favor of advanced imaging. Advanced imaging during the quarter
represented 26.8% of our procedure volume, an increase of 137 basis points from last year's fourth quarter. Higher acuity advanced imaging
drives more revenue per procedure and improved profitability. The strong ending to the year caused us to meet or exceed the principal
2024 guidance ranges of revenue, Adjusted EBITDA and free cash flow in both the imaging center segment as well as Digital Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
finished 2024 with a strong cash and liquidity position. At year end, we had over $740 million of cash on the balance sheet, full availability
of a $282 million revolving credit facility, and a term loan that is priced at SOFR plus 225 basis points, reflective of the financial
repricing transaction we completed, the refinancing transaction we completed in April and the repricing transaction we completed in November.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Continued
improvement in revenue cycle has kept our DSOs, or days sales outstanding, at 32.3 days, near our record low.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">With
regards to our financial leverage as of December 31, 2024, unadjusted for bond and term loan discounts, we had $268.8 million of net
debt, which is our total debt at par value less our cash balance. Note that this debt balance includes RadNet's ownership percentage
of New Jersey Imaging Networks net debt of $41.4 million for which RadNet is neither a borrower nor a guarantor. At year-end, our net
debt to Adjusted EBITDA leverage ratio was below 1x.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
some of you may have seen, we released 2025 financial guidance ranges in conjunction with our financial results press release last night.
While I'm not going to run through all the numbers on this call, I will emphasize some important points.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
January and February of 2025, we experienced severe winter weather conditions. These winter weather conditions were significantly more
severe than the first quarter of 2024, which experienced a relatively mild winter season. As a result, our operations in the Northeast,
Mid-Atlantic and in Houston, which together account for almost 60% of our revenues, were impacted materially. Winter storms impact our
business principally in two ways. First, the patient schedules on the days of the storm suffer from cancellations due to difficult travel
conditions, loss of powers at centers, center closures and the inability of our own staff to come to work. Second, the patient flow of
our referring physicians is similarly impacted, causing a disruption in our scheduled appointments for days following the storm. Unfortunately,
once scanning slots go unused, they are never made up.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
addition to the winter storms on the East Coast and in Houston in January and February, we lost revenue and Adjusted EBITDA as a result
of the Southern California wildfires. Though RadNet suffered no property damage at any of our nearby centers, during and after the fires,
all businesses regardless of industry lost revenue. Populations were displaced and the utilization of health care was not a priority
for those impacted by the wildfires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
estimate that the impact we suffered in January and February from the winter storms and the wildfires was approximately $22 million of
revenue and $15 million of Adjusted EBITDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Fortunately,
our business has bounced back in recent weeks, and we are experiencing strong volumes in line with our original projections. We do not
expect an impact from the severe weather conditions or the wildfires to go beyond the first quarter of this year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
a result of these weather and wildfire impacts in January and February, we modified our full-year 2025 budget and the guidance ranges
for the loss of this revenue and Adjusted EBITDA. Our original projections for the second, third and fourth quarters of 2025 remain unchanged
from the original budget.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
regards to the Digital Health reportable segment, we are anticipating 2025 revenue growth in the neighborhood of 30%. This growth will
continue&mdash;will come from a combination of revenue increases in our clinical AI solutions as well as sales and licensing from the
DeepHealth OS, Smart Technologies and TechLive portfolios.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
growth in Digital Health Adjusted EBITDA is expected to lag revenue growth due to approximately $20 million of planned investments throughout
2025 in the infrastructure which is necessary to support external customers. Areas of investment include sales, marketing, customer support
and implementation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I'd
now like to turn the call back over to Dr. Berger to make some closing remarks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you, Mark.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
we begin 2025, diagnostic imaging is rapidly transitioning into a tech-enabled specialty. Fundamentally, in order to service the growing
demand for diagnostic imaging, which is expected to steadily rise over the next decade and is challenged by labor shortages which appear
to unlikely be abated in the near future, our industry needs to embrace technology solutions that will enhance operational efficiency,
streamline workflow, improve the patient experience and provide better clinical outcomes. It is RadNet's mission to lead the industry
down this path through providing Digital Health solutions, which address the most critical industry needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
announcement that was made earlier this week with OB/GYN Specialists of the Palm Beaches is a case study of how RadNet can be a solution
provider to enable leading-edge diagnostic imaging at the point of care, enabling physician offices, multispecialty medical groups, urgent
care centers in addition to OB/GYN offices with tools to provide high-quality, cost-effective diagnostic imaging, which will increase
access to imaging services, particularly for mammography, ultrasonography and x-ray. These routine imaging procedures represent about
75% of all outpatient imaging services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Furthermore,
tech-enabled point-of-care imaging will create better compliance for routine screening such as mammography and will reduce cost to the
healthcare system by providing additional sites that are more convenient and cost effective. In order to effectively and safely provide
these imaging services, alternative sites of care will need tech-enabled turnkey solutions to manage workflow, professional interpretive
services powered by clinical artificial intelligence, and solutions to improve the effectiveness of on-site or remote technologists.
RadNet is uniquely positioned to lead radiology in this direction because of its 35-plus year experience in building the industry's largest
and most successful outpatient provider, its significant financial and managerial resources, its industry relationships including those
with radiology's largest equipment manufacturers, and more recently, its newly developed array of Digital Health solutions, including
the DeepHealth OS, Smart Mammography, Smart Sonography, TechLive and its ability to develop and commercialize critical clinical AI tools
such as what we have already accomplished in breast, lung, prostate and brain. These essential solutions are driving our continued focus
and investment into Digital Health. 2025 will be an important year for onboarding Digital Health team members in sales, marketing, customer
support and implementation, both internally and externally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Lastly,
we will be opportunistically evaluating acquisitions that serve to either add new products and services and clinical AI solutions and/or
provide us with a customer base to which we can market and sell our portfolio of solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Operator,
we are now ready for the question-and-answer portion of the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
will begin the question and answer session. To ask a question, you may press star, then one on your telephone keypad. If you are using
a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like
to withdraw your question, please press star, then two. At this time, we will pause momentarily to assemble our roster.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Our
first question today will come from David MacDonald with Truist. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>David
MacDonald</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Hey,
good morning, guys. Just one quick question. Just wanted to ask a quick follow-up on the weather impact piece. I just want to confirm
more on the wildfire Southern California piece. As you guys kind of look out at your scheduling and this and that, you expect to be kind
of back to 100% in terms of scheduling either later in March or certainly by the end of the quarter, so no leakage into the second quarter?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Hi
Dave. Let me first put a little context here. The fire storms, and I want to use the word storm - in Southern California, particularly
in the Los Angeles area, Pasadena area, Riverside and Ventura County were like almost a snowstorm in the sense that it impacted virtually
everybody throughout Southern California. Having lived through that because of my location and the corporate headquarters here in Los
Angeles, everybody was impacted by this. I can tell you that on a daily basis people were glued to the television watching these fires
just to get some sense of when relief might occur and when we could start returning back to normal. In addition to that, the air quality
was noticeably dangerous and people were just reluctant to travel, which was all hampered by the fires and the emergency vehicles that
were given, obviously, first priority and being brought in from all over not only Southern California, but other states. So the impact
of this is not just a simple fire, but something that effectively could almost be thought of as like a massive snowstorm that not only
impacted the days and in this case, about 10 days to 2 weeks that this ongoing saga unfolded, but both -- afterwards, both in terms of
people who were unimpacted directly but indirectly and new people that were impacted were reaching out to try to provide their own comfort
and aid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">That
being said, we have recovered. I believe it is back to normal, probably within the last 10 days. and find ourselves slowly increasing
back to or perhaps even exceeding in some areas, the volumes that we had projected for the first quarter. And if you add what we estimate
our loss of business was, impacted by both the fire storms here in Southern California and the severe winter weather conditions on the
East Coast, we probably would have met or exceeded our first quarter budget.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">That
being said&mdash;and more directly to your question, Dave&mdash;we believe that March should be a very normal month for us. As indicated,
as I mentioned, by the improved volumes we're seeing throughout the company over the last 10 days, as well as March being a more normal
month from a climate standpoint that we expect not to be impacted by weather.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
think January and February were extraordinary circumstances that affected not only RadNet, but virtually everybody in those markets in
every business and is unfortunately something that we just have to absorb. But we're extremely confident in the rest of the year and
March going forward that the budget projections and expectations will be met and hopefully exceeded as we have done almost for every
quarter in the last two to three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>David
MacDonald</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Okay.
Great. I guess second question, just I realize it's early, but any early learnings from the OS rollout as you guys start looking at some
of your internal metrics, or just some of the feedback from some of the clinical folks. Just any early learnings there, or is it a bit
too early to start asking for that?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Well,
I think it's a little bit early, Dave. But we have a very close collaboration, as you would anticipate between the Services side and
the Digital Health side in both testing and rolling out the enormous changes that will occur as a result of the DeepHealth operating
system. I think all of our physicians as well as the tech staff and our more administrative staff, particularly in the scheduling, insurance
verification, are all very enthusiastic about the opportunities for a very substantial change in virtually everything that we do. You
would think that this is a logical extension because we're not the first industry to kind of go through these changes, if you will. Things
like remote scheduling and contact centers, other kinds of insurance triaging through bots are all routine in a number of industries.
We happen to be a little bit more complicated because the insurance industry itself is, one, difficult for people to navigate through
in a live presentation, not to mention all of the thought that has to go into creating this. We believe that we're on target to implement
most of the OS system here internally through the three quarters remaining in this year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
we present this to the various constituents in RadNet on the Services side, they come up with very valuable recommendations on how we
can continue to improve it. That, I believe, is a critical part of the value proposition that RadNet plays in creating these DeepHealth
solutions, if you will, that the Services side of our business and the Digital Health side that really was born out of from the Services
side work together very collaboratively and will produce a product that is unlike anything in the industry, from certainly an operational
side and I believe also from the clinical side. I believe that some of the efforts that we're working on in the Digital Health area will
become a little bit clearer as to how we want to be the leading operator and developer of these solutions in the industry, particularly
as I mentioned in some of my closing remarks, into other point-of-care providers that will help drive the access for the increasing demand,
particularly around routine imaging that nobody else is focused on at all, including the OEMs and radiology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>David
MacDonald</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Just
last one for me. Just anything that you would&mdash;I guess, a two-part question. With regards to the pipeline, anything that you'd call
out in terms of either size of deal you're seeing? Anything happening with multiples, etc.? And then I guess the second part of the question
is, can you provide a little bit more detail on the Palm Beach OB/GYN deal? Is that something where they came to you? You guys reached
out to them? Are you getting both incomings and I assume doing outreaches? Just any detail on how that kind of came together would be
interesting. Thank you, guys.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Let's
see, Dave. Yes, yes and yes. They reached out to us because of their own concern and dissatisfaction with some of the professional and
operational relationships that they had.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">It
was a very, what should I say, expeditious conference&mdash;not conference, but call and then ultimately arranging a new solution for
this group, which is quite large. It's the largest provider of OB/GYNE services in the Southern Florida marketplace with 10 offices,
5 of which provide mammography services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">When
we went in, while their focus was primarily on professional services, we quickly were able to have them adopt some of the Digital Health
solutions surrounding scheduling, noticing the patients' visits with both scheduling as well as their annual visits. Sometime in the
first part of March, they'll actually be adopting our EBCD program, which we expect to have very substantial endorsement and adoption
for. What their inquiry originally came from was to provide better quality professional and interpretive services, and we were very quickly
able to add the other operational capabilities as well as artificial intelligence that they had not ever seriously considered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">This
is a case study for us and one where I believe there will be a lot of other opportunities, as I mentioned in my remarks, in the OB/GYNE
area that we want to aggressively pursue both to improve access for mammography to help more of the women that aren't getting their annual
screening done, as well as elevating the quality of the service, to take what we believe is now the standard of care with artificial
intelligence. I'm proud to say that on the East Coast and in our Florida market, well over 50% of our patients are opting in for our
early breast cancer detection. We expect that to even be greater where there's better control of the patient, particularly for the woman
to get that service with their wellness visits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">This
collaboration, I believe, won't take us that long to ramp this up, once we're able to statistically demonstrate to the marketplace the
value proposition that RadNet brings through its various lines of service, not only as a company, but bringing in professional services
also really is looking at the turnkey solutions that I was talking about in my last part of my remarks that I think are really critical
to help decompress also some of the demand for routine imaging that is more and more difficult for outpatient imaging centers as well
as hospitals to absorb.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>David
MacDonald</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Okay.
Thanks very much, guys. Appreciate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thanks,
David.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thanks,
Dave.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
next question comes from Brian Tanquilut with Jefferies. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Hey,
good morning, guys. Maybe, Mark, I'll start with you. As we think about your comment that volume has bounced back after the impact of
the storms, if you can give us some color on kind of what kind of growth rates are you thinking about or contemplating in the guidance
prior to this? And then kind of just any observations in terms of like the demand dynamics in the market?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Sure.
If you were to take the guidance that we released last night and you add back the revenue which we estimated that we lost, meaning the
$22 million, and you look at sort of the midpoint of that guidance range, it implies about a 7% growth there and which we're very, very
confident in and highly achievable, and we're hoping to exceed that as we have in the past few years and adjust our guidance throughout
the year. Within that, we're assuming that, that is being by procedure volume growth and implied in the procedure volume growth is about
a 3% same-store sales growth year-over-year, which is more in line with our historical same-center performance. It's less than what we've
been achieving over the last several years, so I think that there's some potential conservatism built into that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">But
given that we started off the year with January and February and all the impacts of the wildfires and the winter weather conditions on
the East Coast, we didn't have a very good view on the trends in the business because of those impacts and so we wanted to be what we
felt was conservative for the remainder of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Totally
understand. Then maybe, Howard, as I think about the comments on the $20 million of infrastructure investments in the Digital Health
side, if you can walk me through, number one, is this going to be the run rate or do you think you'll have to add to that over time as
the business keeps growing? Then second, what are you seeing in the market for Digital Health that has prompted you to make these investments
today? Do you have visibility to contracts, whether it's hospitals for Digital Health or just other areas of the health care space that
requires you to put that level of investment into the business today?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Good
morning, Brian. Thanks for the question. Before I respond to your question to me, just to add a little color to Mark's remarks, is that
there is no built-in benefit from deploying internally the DeepHealth operating system into the RadNet centers. Additional opportunity,
both on the revenue side as we create capacity and through better workflow and efficiency as well as reducing costs, which we expect
to see predominantly in 2026 when we're fully implemented, some of that may occur, we just can't be certain as to how it will result
in costs that may give us some benefits, but may be duplicative for some period of time as we transition. I want to emphasize that point
that we've put no built-in benefit from what we know we'll see in 2026 into our 2025 forecasting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">But
more to the point here, I think a lot of the $20 million that we talked about will be onetime costs because they'll be primarily in building
sales team, marketing teams, implementation teams and other aspects of taking on this enormous responsibility which we take both seriously
for RadNet's benefit as well as the industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
would tell you that every system that we are partnered with, every opportunity that comes to us for potential acquisition from imaging
center providers, every hospital that we talk to that we have currently joint ventures with or new ones that we're talking to with, which
are rather extensive, all have the same two fundamental problems. Number one, as we mentioned from repeatedly in our quarterly remarks,
the shift of business away from hospitals for outpatient imaging into the outpatient centers, and that's a trend that has accelerated,
particularly after COVID. The other thing is that they're all being challenged by the labor shortage pools and that's not going to go
away, whether it's the shortage that we have for radiologists or the shortage for technologists and other personnel. What we're building
is something that arguably anybody could use to help better drive performance, efficiency and improve quality of care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">When
you look at the potential impact just in the U.S. of this, one of the examples that I gave, there's about 350 million outpatient imaging
procedures done annually. That number continues to grow probably at a 3% to 4% rate, just based on population growth, aging and newer
applications for the technology that's being developed, both in the AI space as well as from the equipment manufacturers themselves.
This increasing demand is something that everybody has to be sensitive to and which the current systems are just not capable of managing,
not only in a cost-effective way, but really at a level of clinical efficiency and quality that the new technology allows us to do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
investment of this could be justified simply to build this for RadNet, but whatever is good for RadNet will be good for anybody else
in the outpatient imaging space. It doesn't mean that everybody is going to run to RadNet, but certainly, nobody else in the space, whether
it's the OEMs or other developers of artificial intelligence or other tools is taking on the magnitude of what we're talking about and
potentially creating the impact, which will be beneficial not only for healthcare&mdash;for imaging providers, hospital or outpatient,
but also for healthcare in lowering cost by detecting disease earlier. That's what these systems ultimately are capable of doing, and
that's where the biggest benefit will be to society as a whole, healthcare in general and radiology in particular. I think that's a very
important social responsibility that at RadNet, we take seriously because I'm not certain who could do it at the scale that we're talking
about and at the rapidity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
want to emphasize to all of our stakeholders, lenders, analysts, we've only been in this business practically a year and a half. We're
not even at the two-year mark since we assembled this team and officially launched at the beginning of 2024, the Digital Health division.
I think what we've done in that relatively short period of time rivals people that have been in this industry and creating products for
10 to 15 years sometimes. So I applaud the efforts of my entire team, both in the Services division as well as the Digital Health division,
and I take very seriously the responsibility that I believe we have to improve and lead radiology and diagnostic imaging into the future.
And that future is here today, not something that we have to wait for us to hit us like a bolt of lightning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
appreciate that. Maybe, Mark, just two quick follow-ups just on Howard's point, right? So as I think about your guidance today, if not
for the storms and the step-up in an investment here, you would have guided to roughly $320 million of EBITDA, so 15%-ish growth. Is
that the right growth rate as we think about 2026 and beyond? Then my second quick follow-up is just the clinical AI revenues, if you
could share that with us for the quarter for Q4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes.
Just on the first part of your question, if you add the $15 million of EBITDA to our guidance levels for both Digital Health and Imaging
Services together, we're about $300 million of EBITDA, which is where we were&mdash;which is where our original budget was for this particular
year. What was the second part?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Clinical
AI revenue for the Q4?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes.
Clinical AI revenues of the Digital Health division for Q4 was about $6.5 million. Let me just look at the report that I've got here.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
can take it offline, Mark.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes.
It's either $6.5 million or $6.7 million of the Digital Health in fourth quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Brian
Tanquilut</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you. Congrats again.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Okay,
thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thanks
Brian.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
next question today will come from John Ransom with Raymond James. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Good
morning everybody. A few for me here. Mark, if we think about the Digital Health revenue guide for '25, can you kind of help us think
about the different components of that, including DeepHealth?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">You
mean DeepHealth OS?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes.
What&rsquo;s coming from DeepHealth versus what&rsquo;s coming from all the other stuff?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes,
sure. Total revenue we expect to be in the range of about $80 million to $90 million. Then of that, we're expecting that the AI component
will be in the range of $25 million to $30 million and then the remainder will be software as well as our other technologies such as
SmartMammo and TechLive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Do
you expect to convert all of your legacy software clients to DeepHealth over time?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Hi
John. Yes, we do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Okay.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
will sunset the older platform for two reasons. Number one, it's an on-prem service that we're still doing, and we will be migrating
the entire company to the cloud, not only for storage, but it will be cloud native so that all of our applications will be in our cloud
network. We hope to have all the 400 centers on that cloud platform, including our legacy system by the end of this year. So all of our
legacy customers will be transitioned over to this new service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
second part of this is that when we talk about the Digital Health division, we really have to focus on three things. One is clinical
AI. The second is the generative AI, which are the processes that we're going to use to change the way our centers operate almost from
the very beginning of calling in for an appointment to the final bill and reporting. But the other piece of this are ways that we believe
uniquely that we can potentially accelerate this growth through the efforts of perhaps looking at other companies that we could acquire.
As opposed to what we've done in the past, where much of our capital has been invested in the imaging services side and will continue
to be that, we will look for opportunistic businesses that are synergistic with our platform to further develop those tools that we think
clinically will help drive not only new revenue but efficiencies in running our business, and allow us to become the leader in the development
of artificial intelligence for mammography, ultrasound and x-ray.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
think the example that I gave and the importance of that was in the example with our latest efforts in the OB/GYNE space, and I mentioned
other areas that we will be pursuing where all of these tools will be transformative and as opposed to perhaps a lot of the focus which
is of the OEMs in their development of the more advanced imaging tools - Meaning MRI, CT, PET CT, areas in mammography and ultrasound
and X-ray have been much slower to adopt a lot of the artificial intelligence that now almost all of the OEMs that we're talking to are
looking for us to take our clinical expertise and help lead the development of some newer tools in that area. Because they all see the
opportunities now and the need to be transformative in the use of this technology throughout the entire range of clinical services that
we provide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">John,
I just want to clarify something or reiterate something. I&rsquo;ve got the numbers in front of me with what Brian asked with regards
to the AI portion of the Digital Health revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Digital Health revenue in the quarter was $18.9 million, and indeed, the AI piece was $6.7 million of that $18.9 million, and that was
a 31.9% growth in just the AI piece from last year's fourth quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">(Inaudible).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
think we lost you, John. We can't hear you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Can
you hear me now?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">(Inaudible).
You guys have done a couple of nice capital raises, but obviously, the money has been kind of sitting there. What are the odds that you
write a check out of that cash this year, do you think?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Well,
I think the odds are very, very high that we will be using some of that capital within 2025. As Howard said in his closing remarks that
some of that capital could be used within the Digital Health segment for acquisitions that could either bring us new products and services
or new clinical AI tools that will be important, not only for our own business but for external customers, or for acquiring businesses
that already have a significant customer base that we could then further penetrate by selling our portfolio of DeepHealth products and
services into. Then there will be&mdash;I'm sorry, John&mdash;there will be also acquisitions, of course, as the normal course of business
on the imaging center side.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Have
you been a little surprised that nothing really has materialized in the core imaging business that has been of interest to you in terms
of bid-ask or size or multiple or what have you?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Your
communication here is a little unclear sometimes, John. I think I understand. We&rsquo;re&hellip;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">It&rsquo;s
not your communication but the sound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
sound communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
don't think we're surprised. As you are aware, a number of the larger consolidators are private equity backed, and I dare say they're
all for sale at the right price. The question is, what's the right price? If it doesn't fit in with the metrics that we think are important
to maintain the appropriate leverage and synergies that we traditionally expect from our acquisitions, we just passed on them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">But
we're actively working on a number of opportunities, both in the Digital Health and in the Imaging Services division, which I believe
we'll be able to talk about later in the year. But we want to be very strategic, and we want to be good stewards of how we use this cash
and it's better for us to keep a good cash balance and ready to move on those deals that we think are accretive, not only from a financial
standpoint but from a long-term future and growth standpoint. I think you'll be hearing more about that from us in the coming quarters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>John
Ransom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">All
right, thanks so much.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thanks,
John.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Take
care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
next question comes from Andrew Mok with Barclays. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Andrew
Mok</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Hi.
Good morning. I wanted to follow up on the labor remarks that you made. I think you said it was unlikely to abate in the future. Can
you provide a bit more color on inflation trends you're seeing in the market? When did you see the acceleration in inflation? How far
along do you think we are in this cycle? Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thanks,
Andrew. I think we started seeing this two years ago.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Really,
in COVID or right after COVID.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">After
COVID. So this is not something that's unexpected. I think what happened in COVID, though, to drive some of the challenges that we and
everybody are facing in healthcare but particularly imaging, is the fact that some people are just throwing in the towel. They're either
retiring earlier or they're being very more specific about where they want to work and how much work that they want to do. It's really
created a different mindset all together here. It was probably something that was already simmering and brewing, but the challenges that
we've had from the labor market are really reflected because of the demand that we have for imaging. That's where the problem has manifested
itself. Because as we have come out of the COVID period, the demand has accelerated, either because of delayed services like has been
reported so much particularly for routine screening procedures, or just the continuing demand that the technology that we are providing
has created in the way of better quality medicine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
driver for that is something that I think has caught everybody by surprise. So it's a combination of supply and demand, the supply of
the labor force not growing and maybe shrinking and the demand accelerating. I think our recognition of this two-plus years ago was really
what drove us into the Digital Health opportunity. We may not have gotten there were it not for this is our solution and for that matter,
everybody's solution to deal with the labor issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">From
a cost standpoint, we are analyzing this and although the industry as a whole probably is low single digits over the last couple of years
in growth of salaries, maybe even more than that&mdash;I'm getting a sign from Mark&mdash;but our internal numbers are that we're managing
control of that into the more...</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We're
in the low single digits. We've seen industry in the mid- to higher single digits, particularly within the hospitals who tend to be sometimes
a little less economically focused, particularly the not-for-profit community-based hospitals, which are the majority of the health systems
out there.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
think we've had a better experience around labor than most in the industries overall in the industry, partly because I think RadNet&mdash;we've
done a concerted effort towards making RadNet a place where people want to work. Particularly radiologists who come here because the
lifestyle is significantly better than in the hospital, the hours are more predictable, they're not on call. And we have a tremendous
amount of pathology that allows our radiologists to subspecialize in the types of scans and modalities that not only they're best equipped
to handle, but also that they most enjoy practicing with. So I think we've had a better experience than most.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">But
having said that, within our guidance, in 2025, we're going to be absorbing about $45 million of salary benefits and wage increase within
our guidance. We're projecting '25 that this trend that we've been facing over the last several years will continue, but I think the
real opportunity for us and the entire industry is adopting the types of solutions, the digital solutions that we're developing and have
developed, and that's going to have an impact in our business really in '26 and beyond once we get that fully implemented with inside
of RadNet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">That's
also what's giving us such great confidence that we're going to be successful in selling and licensing these digital solutions to others
because we're all facing the same issues around labor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Andrew
Mok</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Got
it. Is the radiology labor pressure, is that all current rate in the market? Or do you also have exposure to physician subsidies that
are common in hospital systems?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
subsidies that you're hearing about are from hospital-based radiology groups only agreeing to work for the hospitals if the hospitals
subsidize them because they simply can't make enough money by billing for the professional-only component with inside of the hospital.
Because remember, the hospital is billing and collecting for the technical component.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
our business, for the most part we make our money on the technical component and the physicians are paid out of the global bill, but
are receiving essentially the lion's share, if not all, of the professional component of the global bill. Subsidies really aren't applicable
to the outpatient industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Andrew
Mok</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Got
it. That's helpful. Then maybe just finally, can you talk maybe about the switching costs of PACS and RIS as it relates to DeepHealth.
I think a lot of attention is on the AI side and rightfully so. I just want to understand how this part of the sales cycle works. How
much of a barrier is it to switch on to DeepHealth's PACS and RIS systems for a new customer, even if that customer really likes those
products? Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Well,
the PACS business, like a lot of software businesses, if you will; it goes through cycles, if you will. The cycle that we're in now are
that most people are using PACS systems that are perhaps 10-plus years old and don't support the kind of productivity and other tools
that can improve the efficiency of the radiologist. Our systems are designed to actually be the next generation of PACS. We don't like
using the term PACS because I think that's an old term, and a lot of the benefit that we're talking about will be using newer software-engineered
tools that can reside in the cloud and therefore, create better use of the radiologists' time, both to read the study as well as utilize
artificial intelligence to kind of aid, if you will, in the diagnostic work of what they do. Maybe with something as simple as triaging
what artificial intelligence would call normals to not normals and allowing more time to be spent doing the work of those cases that
need more evaluation, if you will, and less time for those that are normal. Remember, the majority of what we do is normal, so even a
triaging tool where the radiologists can trust the AI to be very accurate in that will allow a lot of improvement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">That's
what's perhaps a little bit different about the hospital space versus the outpatient space. We can bring these tools and truly make our
radiologists more productive and they will earn more by reading more, whereas in the hospital, while you would think some of this would
be applicable and it will be, the cases and the pathology that they see in a hospital are far more complicated in terms of evaluating
why the person is in the hospital and a much greater percentage are abnormal than in the outpatient space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
think the real opportunity here is for the new technology to utilize newer computer science to develop better and faster software for
doing these same functions, if you will, and then bringing it into the cloud to make that functionality for what they're looking at,
for looking at priors, comparing priors with more targeted software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">One
of the best examples I can give is that the newer technology is generating in some cases hundreds of images that used to be just a handful
of images, and it's very difficult for the average radiologist to be looking at that many images. A lot of the artificial intelligence
and work that we'll do will cone down the relevant images by applying the artificial intelligence to that which they were looking for
given why the patient was referred, but also perhaps looking at other things that weren't ordered that may be opportunistic in the way
of evaluating early diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">That's
why this whole evolution of PACS is not just about reading. It's about what you're providing for the read additionally that helps make
it more efficient, more accurate and more trustworthy than the prior PACS systems.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">One
thing I want to emphasize, Andrew, going back to your question about how likely&mdash;what are the impediments to switching PAC systems
from a radiologist standpoint. When you look at the overall industry for PACS today, a very small percentage&mdash;I believe the last
report I saw was about 15% of all the PACS systems out there are cloud-based systems today. So the vast majority of people out there,
radiologists are using on-premises software. When you look at the benefits of cloud-based in terms of the ability to compress data sets,
the ability to do cloud-based storage, cloud-based retrieval, the speed at which you can look through prior images and call up prior
studies, the viewer technology that's there today that allows for visualization tools, it's so far superior in the cloud versus on-premises
software that, as Howard said, there's going to be a cycle in this industry in the coming years where the radiologists are going to switch
from these on-premises systems to cloud-based solutions, like they have within other industries and other areas of software development,
and that's the cycle that DeepHealth is preparing for.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Andrew
Mok</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Great.
Thanks for the color.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
next question today will come from Larry Solow with CJS Securities . Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Larry
Solow</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Great.
Good morning, guys. A lot of my questions have been answered. Thanks for all the color, guys. A couple of follow-ups, I guess. You mentioned,
Mark, that the $45 million increase in wages and benefits, it sounds like the biggest driver, but just overall, it looks like EBITDA
margin, even if you add back the onetime or the $15 million impact, you have segment margin actually declining about 40, 50 bps year-over-year.
I assume maybe that's just the impact of the higher wages or what else is driving that? Because it seems like there are a lot more good
guys than bad guys in the imaging piece, so what else is driving that contraction?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Sure.
When we built our guidance&mdash;and just to give you a little bit of color on how we built our guidance, when we're doing our internal
budgeting, we're building it from the bottoms up. We go to every center level manager, every regional manager, we are projecting volumes
by site based upon the opportunities, risks of that particular center. We build it up to a corporate level and then we layer on all the
corporate functions. Then embedded in that, then we'll go back and say, &ldquo;Well, does that assume&mdash;what kind of growth does
that assume from a same-center performance basis?&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">From
a labor standpoint, when we go back and look at on a same-center basis, we're assuming about a 4% increase in the same-center labor rates,
which is somewhat consistent with what we faced in the last few years. The overall margin, EBITDA margin flows out of that same budgeting
process. What it showed this year is that we're expecting to have fairly stable margins relative to last year; it might be a little bit
up or flat. The opportunity, we think, for margin enhancement is going to occur once we put in the DeepHealth OS platform and adopt a
number of these automation tools throughout the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
could see some upside to that margin maybe in the second half of the year, but what we're really projecting and excited about is what
this could mean for the profitability and margin enhancement in '26 and beyond once we have it fully implemented with inside of RadNet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Larry
Solow</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Is
there any like temporary&mdash;clearly, there's a little bit of a learning curve to get some of the upside and some of the benefits.
Is there any temporary actually negatives efficiency-wise as you implement some of these systems? Or maybe super short term it should
not matter, but does that factually actually potentially happen?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
don't think so, Larry. The way we're implementing this is region-by-region, and we're starting with the implementation or have started
with the implementation in some of our smaller regions so that we can work out some of the kinks before we get to Maryland, New York,
California, where we have much more substantial and much more complex operations and complex workflows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We've
done this before with our eRAD product over the years and I think we're not concerned about this. It's something that we've had experience
with in the past.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Larry
Solow</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Got
it. Okay. Just segueing into&mdash;this is my last question. You mentioned the internal potential benefits and efficiencies from Digital
Health. What about just on the Digital Health piece itself, and this year obviously it sounds like you're continuing that targeted 30%
plus growth. As we look out five years&mdash;and not looking for an exact number, I realize that&mdash;this business, is this sort of
growth sustainable? Like if we grow this business 30% for the next five years, maybe it can grow faster. It feels like we're somewhat
in the infancy, but it could be a several&mdash;a $300 million dollar business. Is that far fetched? I guess at that level, I would imagine
margins would be probably over 30%, maybe even higher than that. Just any way to kind of ballpark that as you look out maybe five years,
plus or minus? Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Well,
without giving multiyear guidance because I don't think we're in a position to do that, I don't think that what you're saying is far-fetched
at all. In fact, we're making substantial investments today. As Dr. Berger mentioned, over $20 million worth of investments in DeepHealth
to build the infrastructure to support a much larger business with external customers. The opportunity that we see is that we're going
after what today is about a $4.5 billion worldwide market in radiology software which we believe will continue to grow substantially
and which will have that switch towards cloud-based computing in the next decade.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">There
is no one company out there that is a category killer. In other words, this is not like an industry where you've got a couple of operating
systems like Microsoft Windows and Apple OS. This is an industry that is highly fragmented, that is mostly comprised of small developers
or even OEMs who have created point solutions that are focused on a particular modality or a particular problem or disease process. What
we're building here is something or an underlying technology that could be ubiquitous and that could be a very substantial business if
we're successful, and which would create a kernel of technology that could underlie a lot of these point solutions, which can run on
top of it that we&rsquo;ll develop and there will be other people in the industry that will develop those point solutions. But yes, we
think that this is a big opportunity and which is why we're spending a lot of resources, both financial and otherwise, to build the infrastructure
to go after.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Larry
Solow</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Great.
Thanks, Mark. I appreciate all the color.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Again,
if you have a question, please press star, then one.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Our
next question comes from Jim Sidoti with Sidoti &amp; Company. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Jim
Sidoti</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Hi,
good morning, and thanks again for taking the questions. Just two quick ones. One, how long do you think it will take for the sales and
marketing team that you&rsquo;re bringing in for the AI business to get trained and to actually start to contribute to revenue?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Well,
we hope to be able to complete that in this calendar year. There is more than one way to accomplish that. We'll be looking at various
alternatives that we have to scaling up quickly for this, but the process itself, I would hope one way or the other will be substantially
complete by the end of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Jim
Sidoti</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Okay.
Then just a modeling question. The capitation revenue, it was down in the quarter and the year. Is that a trend going forward? Do you
think that people are not opting for that model going forward? Was there something specific in the back half of this year that drove
that?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="image_005.jpg" ALT="">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Yes.
No, thanks for the question and a good observation. Our capitation revenue this quarter was about 6.6%. At the height of our capitation,
we were north of 10%. This is intentional. As you can see, our overall revenue is going up and what we've done as part of our efforts
that we've focused on several years ago in going back to our payors in general to get price increases, we've been highly successful with
some commercial payors, some capitated payors, but others on the capitation side we haven't reached agreement with, and from our perspective,
when we benchmark each capitation contract relative to the other books of business that we have, we need to be paid fairly for the services
that we're providing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
several cases over the last, say, 24 months, we have flipped a number of these capitation contracts to fee-for-service arrangements where
they're no longer obligated in sending us 100% of their patients, but that which they do send us, we're now enjoying at significantly
higher fee-for-service rate. And given the fact that our centers are so busy, many of them have backlogs, it doesn't make sense in us
seeing capitation patients if the rates are not on par with the other books of business that we have. We've actually benefited from flipping
these contracts to fee-for-service, so you'll see the capitation revenue has declined, but our overall revenue has gone up.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">I
believe&mdash;and we've gone through some of these cycles before. I believe that some of these contracts will end up coming back to us
in the future when they recognize that holding the risk themselves and doling out the business on a fee-for-service basis to RadNet and
others out there that might be able to service them has cost them more money than if they would have initially agreed to the increases
that we're requesting. We'll see how it plays out in the coming years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Jim
Sidoti</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you for explaining that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Mark
Stolper</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">My
pleasure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">This
concludes our question-and-answer session. I would like to turn the conference back over to Dr. Berger for any additional closing remarks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Howard
Berger</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you, Operator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Again,
I would like to take the opportunity to thank all of our shareholders for their continued support and the employees of RadNet for their
dedication and hard work. Management will continue its endeavor to be a market leader&mdash;or the market leader that provides great
services with an appropriate return on investment for all stakeholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Thank
you for your time today and I look forward to our next call. Good day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
conference has now concluded. Thank you for attending today&rsquo;s presentation. You may now disconnect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&#160;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1-888-562-0262 1-604-929-1352 www.viavid.com</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rdnt-20250227.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaOE6aPty552mYkxvmR5fflKjyIkSH6JqC4pPx3mgb8I -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:RDNT="http://radnet.com/20250227" elementFormDefault="qualified" targetNamespace="http://radnet.com/20250227">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20250227_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20250227_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>rdnt-20250227_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>rdnt-20250227_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20250227.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'W L0# 2(  A$! Q$!_\0
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MWY5I4E/V2[B^L/L9WEO_ '&_*CRW_N-^5:%%'LEW#ZP^QG^6_P#<;\J/+?\
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M_P#Y"-S_ -=7_F:W;7_CTA_ZYK_*L*__ .0C<_\ 75_YFMVU_P"/2'_KFO\
M*L(G;4V):***LQ"BBB@ HHHH *,444 )12TE @HHHH *2EHH&)1110(****
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MH **** $HI:2@04444 %)2T4#$HHHH$%%%% !24M% "4444P"BBB@0E%+24
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M*!!24M%(!****8"8HI:* &T4M% A,4E+10 E%%%,0E%+24 )1BEHH ;12TE
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MKYV[,=>GWC78^ ]6O-=\$:5J=_(LEU<1%I&50H)W$=!]*\M_:+_YEW_MX_\
M:=>B?"O_ ))EH7_7!O\ T-JE;FC^%'84E+15$"5%<W,-G:S75S(L4$*&21V.
M J@9)/X5+7C'QU\9&VLHO"EC(3/<@27>WJL>?E3ZL1GZ >M)NP)7=CBKWXS^
M(W\8/J-I=NNE+<!H[ A0K1#C:3C.2.2<\$U](:3JEIK6DVNI6,GF6US&)(V]
MCV/H1T(]17E4'PA1OA)_9CPJ->?_ $T.1R)L<19]-OR^F>:PO@=XR?3]1E\)
M:D[)',[-:"3CRY1]Z/GIG&<>H/<U*NMS2236G0]^I*6FNZQHSNP5%&68G  ]
M:LR,O7-=AT2W1WC,LLA(2,'&<=23V%5M!\3Q:S*\#0F"=5W!=VX,/8UFZS_9
MOB[:NBZO8W5W:YW113JQVG'H>/KTJOHFG0^&[S[9K5]:VKLI6*-Y0"<]37D5
MJF-AC5&UJ?IT]>Y[4*> ^H.<Y?O/7KTT['<5X1\6-0\7^#O$4-]I^N7PTJ\.
MZ)"^Y8Y!]Y#GMW&>Q([5[I%+'/$LL,BR1L,JZ'((]B*Q?%_AFV\7>&KO2+C"
MF1=T,I&?*D'W6_Q]02.]>LU=:'C1:3#PAXEM_%OAFTU>WPID7;-&#_JY!]Y?
MSZ>Q![UN$X&3TKYO^%'B2Y\%>-KCPWJ^Z&WNIO(D1SQ%.#A6^AZ9[Y4]!7I'
MQE\7_P#".^%#I]K)MU#4PT2X/*1?QM^1VCZY[4*6@W#WK(X;4/&GB7QQ\3AI
M/AC5KFTT[S/)1H#\OEK]^4^N>2/;:.M>_0Q^3!'%O=]BA=SG+' ZD]S7E_P3
M\&_V)X>.N7D6+[4E!C##F.#JH_X%][Z;?2O4Z(]PFU>R$HI:2J(/!_C/XMU_
M0O&5M:Z7JUU:0-8)(8XGP"Q>0$_D!^5>W:<[2Z9:2.Q9VA1F)[D@5\\?'W_D
M?;3_ +!L?_HR2OH72_\ D$67_7!/_014K=ER7NHM44M%69GC/QN\3:WH&HZ0
MFDZG<6:2PR&01-C<01C-8.G:7\7]5TVVU"TU6X>WN8UEC8WJ E2,C@GBK'[0
MO_(5T/\ ZX2_^A+7K'@'_DGV@?\ 7A%_Z"*SM=FM[13/)VT?XU60,R7EQ,1_
M"+J)_P!&-6O#/QFU.PUD:/XTM!$0XC>X$9C>$^KKT(]QCUYKW&O ?V@[.WCU
MC1;M%47$T$B2$=2JE=N?^^FIM6U01:D[-'O8(8 @@@\@BBN;^'=S+=_#S0I9
MB2_V15R>I"_*#^0%=+5F+5G82BEI*!"44M)3 2BEHH$)24M% #:2G4E A**6
MDI@)24ZDH$)28IU)0 VBG4F*8AM%+10 W%)3J3% AM%.Q24Q"8HHHH J7_\
MR$;G_KJ_\S6Q;?\ 'K%_N#^58]__ ,A&Y_ZZO_,UL6W_ ![1?[@_E7- [ZNR
M):6DHK0Q%HHHH 7-%)10 M%%% !1110,6BDI:0!1110 49HHH 6BDI:!A111
M0(*6DHH 6BBB@84444 >0?'/P5_:>DIXELHLW=BNVY"CEX?[WU4_H3Z5Y3#J
M7B#XDWGAWPN\FX6J^2CX)PO>1_4J@ _#U-?6<D:31/%(BO&X*LK#((/4&N6\
M+_#OP]X/OY[W2H)1/,GEEI7W[5SG ].WY"I:U-%*R-[2-+M=$TBUTRRCV6UM
M&(T'? [GW/4GU-7:**HS"BBB@#PK]HO_ )EW_MX_]IUZ)\*_^29:%_UP/_H;
M5<\6>!=%\:?9/[72=OLN_P ORI-GWL9S_P!\BM;1='M- T:VTJQ#BVMEVQAV
MW'&2>3^-*VMRF_=L7J***9!E^(M=M?#6@7FKWA_<VT9;:#R[=%4>Y.!^->"_
M"_1;OQ[\0KKQ1JX\R&UE^T.2/E:8_<0>R@9]MJCO7OVKZ'IFO6J6NJV<5W C
M^8L<HR V",_D3^=+I.BZ;H5F;32[*&T@+ERD2X!8XR?KP/RI-79:E9%ZOG7X
MT^$Y?#WB6#Q3I@:&&[E#.T?'E7(YW#TW8W?4-7T75/4]+L=8L9++4;6*YM9,
M%HI%R#@Y'ZBAJXHNS,+P!XMB\9>%;?41M6Z3]U=1C^"4#G\#P1]?:LSXOQ:A
M+\/+P6 <A9$:X"=3$#ST[9P3[ UTNC>&=%\/-,VD:=!9F8 2>4N-^,XS],G\
MZUB 001D&M:,_9S4[7L)VOH?)OP_34'\>:-_9H<SK=(6*]H\_/GVVYS[5Z#\
M0([M/&%XUT&VMM,)/0I@8Q^OXYKV>TTRPL'=[.QMK=W^^T,2H6^N!S4D]K;W
M2JMQ;Q3!3D"1 V/SHS:?U^UO=L<N)H>VARWL<;\+X[M/#DQG#"!IR8 WI@9(
M]L_KFNWH"A5"@  < #M17/1I^S@H7O8UI0]G!0['B'QU\%[XT\66,?S)MBO@
MHZCHDGX<*?\ @/H:X[PC8:K\5O'=K+K4K7%K90Q_:7Q@>6GW4^KG.?JQ[5]-
M75K!?6DUI=1++;S(8Y(W&0RD8(-4=%\.:/X=BEBTC3X;-)6#2",?>(Z9JW'4
MZ%.RL::JJJ%4!5 P !P!12T4S(2BBBF!\W?'[_D?K3_L&Q_^C)*^A=+_ .01
M9?\ 7!/_ $$5GZQX.\/>(+Q;O5M*@N[A4$8DDSD*"2!P?4G\ZVHXTBB2.-0J
M( J@=@.E)+4IRNDA:2EHID'@?[0W_(5T/_KA+_Z$M:?A?XS^&=&\+:7IES;Z
MDT]K:QQ2%(5*E@,''S=*]0UKPKH?B*2*35]-ANWA!6,R9^4'KT-9?_"LO!?_
M $+UG^3?XU-G>Z-.:-K,Y&Z^/_AV.,FUTW4II.P=413^.X_RKS6Z?Q)\8_%Z
M2Q6GEQ(!$"H)BM8\YRS=SR3ZGL*]\A^'/@Z!PZ>'; D?WX]WZ'-=%;VT%I L
M%M#'#$O"I&H51] *+-[AS1CLB#2M-AT?2+/3;;/DVL*PH3U(48R?>K=+15F0
ME)2T4 -HI:2@08I*6B@!*2EHIB$HI:2@!*2G4E #:*6BF(2DI:* &T4M% AN
M*2G4F*8A*2G8I* $I,4[%)0(;12XHH I7_\ R$;G_KJ_\S6O;_\ 'M%_N#^5
M9%__ ,A&Y_ZZO_,UKV__ ![1?[@_E7/ [JNR):7--I:T,!:6FTM Q:*2EH *
M6DHH 6BDI:0!1113&&:6DHH 6BBBD 4444 +1244 +1110 4M)10 M%)2T#"
MBBB@#!G\2M]HN8[#3+F^CM25GEC(558=0,_>(]!1/XH@VVB6-K/>7-U'YJ0(
M I5<XRQ/ YR/PJA9?VKX=-[9QZ3+>QRSO-;S1.N#NQPV3QBD^S:W8:K:ZU-:
M+>S26GV>ZB@(!0[MP*YZ]A^=3<NR-&W\31R07_VBSFMKNRA::2VDQEE SE3T
M(]ZJ/XTCAMH+VXTN\CL9^$G^4Y;&<;<Y['![U"^G:EJ<VKZG/9FV:73GL[:W
M+ NV03DXX'/%37NEW<OAG0[1;<M-;R6QF3(^4*/F_*C4+(NV/B![C5%T^\TZ
M>RFEC,D/F,K;U'7IT/M6?%XV673?[172;PV:-MEE!7"'..!G)[?G5Z]L;F7Q
MEIEZD1-O%!(KR9&%)!Q678Z/?Q?#J;37MF%XRN!%D9.6R.^*-0T-"'Q3YEW9
MK+IEU#:WK!+>X<C#D],J.1GM6EIVIIJ,M[&D;(;6<P,2?O$=Q6;J6GW4T?A]
M8H2?LUQ$\H!'R*%P35:W_M71=3U1(]*DNTN[@SP21NH4$CHV3Q3%9,E_X3"#
M^Q[/419SLMU.85B0@MGG\^E6;'Q T^J+IUYIT]E<21F2(2,K!P.O([^U8>G:
M'J,.C:#;RVI$EMJ'FRKD?*N3SU]Q6[?65Q+XKTJ[2(F"&.99'R/E) Q2U!I%
M33]>M;/P]#<EKVX:6=HHHY6\R:1MQ& >/_U5;M?$!:XDM[^PGL94A,ZAR'#H
M.N"O?VK"AT34[?1M+N([7?=V%W)*;9G +HS'H>F<8K3>\\0:D;@6MD;"$6[!
M3<8+M*1QC!X'N: :0DGBQX+9+Z?1[R+3G(Q<,5R 3@$KG('2E?4]0'CH6(MY
M&M1:;MH=0.7 ,OX=,=?:N;O-#O[_ $7RETB_?4< RW%W=9&0<G8-V#GZ=*Z:
M>*]B\7VNI+8R2V\UD+9RC#,3%]Q)]@/2C4=D16>OVMCHQG)O;AY+MX8HI'$D
MCOGH.G'\JMVGB%I-1BL+_3Y["><$P^80ROCDC([X[5AQZ'J<&GVES':[KJSO
MY9Q S@>8C'L>F:T?+U'7-9TZXET][&ULF:4F9E+R,1C  Z#WHU$T@7Q<\T,\
M]OH]W-!;LRS2!E 7;UQD_-Q@U;N?$D*K8+9VLMW/?1F2&-2J?+C/))P*KZ5I
MUW;^&-0M982L\K3E$R.=V<?G69)I5TNB:1;WFBK>P11%9D1L3Q-V*D,..G%&
MH61TVEZF=1$RR6D]K- ^QXY1^H(X(J+5=:&G7-M:16LEU=W.[RXD8+P!R23P
M*H^%[/4+5[TW"W$5DQ7[+!<RB1T&.>1T'M_DKXFLY+N6U\S2$U"S7=Y@0[9H
MSV*G(X]O:G?05E<;?:T)_#^HR3V]_926Q59%1@CC)&"C\@U)-XA^RW=MIT%C
M<W=Q+:K.@5AD@Y'S$XQTZUBC2-6?0-9MUANA;S!!9VUQ*'D7!!;G/ ]O\G9L
M]/NH_%%O=O"1 NE+ 7R.)-^<?E1J.R(4\7O<),+;1[N66VS]J0LJ^5C/?/)X
M/ J:Y\5V\4.F2PVL]Q_:"L8EC W KC@CZG'X4:;I]S FO^9"5-S<2/%R/G4K
MQ7/&.^TC_A$H_L9DNXA<@P%@"<XSSTS@TM0LCI$UTW O+*>UGL;Z.W:54<@[
MEP1N5AUP:SK"_?[#X;:::\EN)UDP%FP)"%S\^?O>U3BUO]6U274I[)[2**T>
M&&*1@7D9NY Z"H;32;Z./PP'MV!M/,\_D?)E<#_(IAH9:7-U<S:WJ%\-3B2V
M=U'DW840\ ;  >O/7&*Z.XUY;5K2RM;6>]O981((E8 A<=68\5GR:3?'2/$D
M(MV\RZN'>!<CYP<8-0:CH<\>J6VH/I\U[ UJD,L4,YCDC88Y&",CVHU#1FS;
M>);62VO)+N*6SEL@#/#*/F4'H1CKFL;6O$%Y+8VVVPOK!9KB/RYBP&X9Y!P<
MC([&B+PY+?Z9JRBP73S<JJP"69Y)&"D-\Y+$ 9'84_59-;U>TMK0Z)+"\<\;
MS.9%*\'^'GFC4$E<Z^BJZW$[:C);M:,L"H&6XW##'^[CK5BJ,A**6DI@%)2T
M4"$I,4ZDH 2DIU)0(2DI:* $HI:2F E%+10(;12T4 -I*=24"$I*6BF E)3J
M2@0E)BEHH ;12XI*8A**6B@"A?\ _(1N?^NK_P S6O;_ /'M%_N#^59%_P#\
MA&Y_ZZO_ #-:UO\ \>T7^X/Y5SP.VKLB6BBBM3G%HI*7-(8M%)10 ZBDHH&+
M1110 M%)2T@"BBBF 4M)10,6BDI:0!1110 4M)10 M%)2T#"BBB@0M%)1F@8
MM%%% !1110 4444 %%%% !1110 E%+10 E%%% @I,4M% Q**6DH$%%%% !24
MM% "56GT^UNKNVNIHMTUL6,+;B-NX8/ .#T[U:I*8!1110 8I*6BD(2BBBF
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MT +124M PHHHH 6BDI:0!1113&%+244 +1112 **** "EI** %HHHH&%%%%
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MPH^X*RCTQD#Z;:][_P"$;_ZC.K?WO^/G_EI_?Z?^._<_V:/^$;_ZC&K?WO\
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M&:*0!1110 4M)10 M%%% PHHHH$+124M PHHHH **** "BBB@ HHHH ****
M$HI:*!"4444 %)2T4#$HI:2@04444 %)2T4 )1113 ****!"44M% "4444 )
M12T8H ;12TE A**6B@!****8A**6B@#$O_\ D(W/_75_YFKD7^I3_=%4[_\
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MO$94>RTJ&..*'!RDCK("O'&,'&1QS7KUIHFDV$4\5GI=E;1W'^N2&W1!)_O
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MDN<*0"N>F"<8''S CK7*V_V:\^&^GV%QXQS%)<!%T2TTF&6Y24L<$$NK'/\
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M^3'&%3!ZC:!BH8M%TJ#37TV+3+*.P?.^U2!1$V>N4Q@_E2L/F/#O%KM)\&_
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MBBD M+3:6@8M+244 +124M !2TE% Q:6DHI +2TE% Q:*** "EI** %HHHI
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M24M PHHHH$+1244 +1110,**** "BBB@ HHHH **** "DI:* $HHHH$%%%%
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M% @I:2B@!:*2EH&%%%% !1110 4444 %%%% !28I:* $HI:2@04444 <]?\
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A #-+110,****!!1110 M%%% PHHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  < KP# 2(  A$! Q$!_\0
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MY9YW=2!CH2<X>R\C>^RQ_P#/-/R%)]DC_P">:_D*;H]ZVLZ);W_E&V%TADC
M;<0ASL;D=2N#C'&<<UQU^9-(O]372]:O%@L]*G;4+N^G>XCAN,*83@YVOC>Q
M1 !@K\O*BCF%[-'9_98_^>:_E2?98_\ GFOY5S7@XW4.L7=C<O?PK]C@E6TU
M&X:>8ME@\H<DX1L*-N[(*G*KD9ZG4;%;VS:![FXMHR07>"3RV*@Y(W#E0>A(
M(/H13YF#IJY']EC_ .>:_E2?98_^>:_E7#6\]U<&UL8;S4#HFI:T8K2=KF3S
MGMTMS(VV7=OV-*APV<E<X."*N6C07/A$WFM:IJB16$]S9K]GNI(GF*3-'&<H
M0\DA"JH!)W$G@DTN</9(ZS[+'_<7\J/LJ?W%_*N0O$UU[#PM!J-GK-W/]E>;
M45TR;R&,@10%9Q(@SEB<!N2IP#77Z)<6E_HEG=6#RO:R1 QM,S,^.GS%B6+=
MCDYS3YQ.DA/LJ?W%_*C[*G]Q?RK0\ND\NGS"]FC/^RI_<7\J/LJ?W%_*M#RZ
M3R_:CF%[-&?]E3^XOY4?9E_N#\JT/+]J3R_:CF#V:,_[,O\ <'Y4GV9?[H_*
MM'R_:D\NGS"]FC/^S+_='Y4GV9?[H_*M'RZ3RA1S![-&=]F7^Z/RH^S+_='Y
M5H^51Y5',+V:,W[,/[HI/LX_NBM+RJ/*I\P>S1F_9QZ"D^SCTK2\JD\JCF%[
M,S?LX]*/LX]*TO*]J3RO:CF#V9F_9_:H94V.![5L>3[5FWZ[9U'^S_4U4979
MG.%E<MF8X." >V:X[_A'M3;1;[2I&LI+>]GEED9F8,LCN9/-4@#!5N0G; ^>
MNBWMZTN]O6HE34NIO2Q3IW]U/U5_U1R,_A'6+F25I-20B::&690P DFB"!9S
M\F<GRUS']WW'&)?^$5U<7L<RWL*017GVN.S5SY23'EI1\N[!)8^66QECAAQC
MJ=[>M+O;UJ/8+N_O.C^T'_)'_P !_P""<Q=^%M0OM O=&N#9/;7=Q+,S;F#I
M(\AD,JG'&"3A/3@L:?=^'M=N+A9[?4(K"4VPLIGM'*F:,9VNQ*G!&6P%VL-Q
M^?ICI=[>M+O:CV*[O[P^OO\ DC_X#_P3#M-(UVUU&\NH;VWB^V/$)@I+?<"K
MY@+*3DJH4H2?7<#S6_J]C!K6FO8W+R+$[HY,9 ;*.''4'NHIF]J=O;UJXT[*
MQA4Q#J.]DO16_P RC'X9T](K6+S;ADMM0DU%0S*<R/YF0>/N_O6XZ\#GU73O
M#Z:6@BMM6U(6\430VL!D39;*>FT;?GVX 7S-^,>YS=WFEWMZT^1$>U9>63:@
M!8L0,%CC)]^*7S?>J.\TN\^M'*+G"ST^"QU'4;V)Y#+?RI+*&(P"L:H-O'3"
MCKGG-4+OPQ97FHRW+7%TD%Q+'/<V:,ODSR1XVNV5+9^5,@, =HR#SF_O:EWG
MUI<I7M&95_X2L]0O;J=KZ^ABNYH;B>VB=!'))$5VL<J6'W%! .#CIGFIAX8L
MDM8(([BZ0P:B^HQR H6$KLY8<J1M_>,.F<'KGFM#>?6EWFCE0_:,H1>&;"*.
MT19;C%KJ,FI)EEYE?S,@\?=_>M@=>!SZW-5TN'51 YGGM;JV??!=6[ 21$\$
M#<"I!'!# @^F0"'[S2[SZTN4/:,YVU\!65M:7UJVJ:E/'>-&[-*8M\3QL&C,
M95!M"D<)@J.P SFP?!MJ9'N/[5U+[<UVMY]L+1&02+%Y60#'LP4XQM^F*VPY
M]:7<:.1#]HS,M/"MA9QV*)<7;BSOI;^,R."3)('#!CCD?O&/KTYI'\*69BD6
M.]O(9/MS:A!-&4WVTK$[]F4((;<P(<-]X^V-3>?6EWGUHY4'M&4K30(+;4;2
M_>^OKJZMHYHQ)<2AM_FLK,2, #!08"X4#C%/U[14UZ.U22_N[46TPG40",AV
M'W=RR(P.#R..#@]0,6]QHWFCE#G9F7OAO[?!;^?K6I?;(!(J7J>2LOER !T(
M$>S!PI^[G*CFHW\)Q+J,-Y8ZMJ%@8+5;2"*!8&2&)>R>9&Q7.!G!YP,]!C8W
MFC<:7*/VC,S6_".A^(;=EU&PMY;AE13>&",SX4@_>*\9Q@^Q-7M3TFTU325T
MQPT-LKPNJP87;Y;JZ@<$ 90#&.GI4VXTNXT<H<[(]6TV#6;6*WN'D5([B*X!
MC(!W1N'4<@\949]JH)X6T](;6+S;DK;:C+J*99>9)/,W \?=_>M@=>!SZZ>X
MTNXT<H^=F)I7@ZSTJYLIH[^_F%E;O:V\<SIMCA;;\N%09QM')Y]2>*>O@S2/
ML.FV4WGSVUA8RV"1R.,212! V_ !SA!@C'4_AL[C1N/K2Y4'.S'/A2*:W6&]
MUC5;W9+!(C3RH-ODN'4!515Y(Y8C<1QG@8B'@JQ%W'-]OU#RHKR2\BM]Z>7'
M)('WX^3)!\QOO$X[8YSO;CZT;CZT<H^=E)= LU\(_P#"-"2?[%]B-COW#S/+
M*;,YQC=CVQGM3[G1+6YFTN<2SPSZ:V898R-Q4C#(V0058 9'L""" :M[C1N-
M'*'.S*@\,06UZ\L&I:E%:-.]Q]@BF"0B1P=QRH#X)9FV[]N3G' Q&GA"SD^T
M_P!H7U_J/GV3V -TZ;HX&^\H9%4DG"_,Q8\=>N=G<:7<:.4?.SGAX&LI)A/=
M:GJ5W.!;*))GCSM@E\Q!A4 QGKQR/?FKB^&4@6<6>KZE9M)>27@,+Q_(TF2Z
M[60JRDDGYPQ!Z$5K;C1N-+E#G9%H^F6VBZ7#I]J7,4>YMSD;G9F+,QP ,EF)
MX '/  K)'@ZSYM_[0O\ ^RC-YW]E[T^SYSNV_<W[-WS;-^WMC'%;FXTN318.
M=F/!X3L8-32Z6YNFMXKE[N&Q9D\B*=P=SK\N[)+.<%BH+' '&'1>%;"&.T19
MKDBUU*34DRR\ROYF0>/N_O6P.O Y]=;<:7)HL'.S&'A*QCT+3M+@N;N$Z:XD
MM+M&3SHF&1GE2IR&92"I!!Z=#4MKX;M[>_M;Z6\O;NYMXIX]]S*'\P2LK-D8
M 'W  %PH'&*U,FC<:+#YF<\/!%I_9D^EMJNJMISVTMI#:F90EO&_&%PH+8'"
MF0O@=.]6;_PEIVHW$T\TEP)9+6&V5D8 Q>4[21R+Q]\,V><C@<8SG8W&ER:+
M!S,QI?"\=Q;*)]6U.6]CN!<PWS2)YL+A=OR*$\L KD$;,'<2<GFM33;+^SK3
MR#=W5VY=G>:ZDWNQ8Y/0  >BJ  .@%2[C2Y-%@YC _X0VS&;?[??_P!E&;SO
M[+WI]GSG=M^YOV;OFV;]O;&.*+_P997][=7#7]_%'=7$-U+;Q.@C,T>S:_*%
MNB*,9V]\9YK?W&EW&E8?,SGX/"-OIS&ZTZYN5O(X;M(&D==H:>3S23\AZ,!C
M@X'4-6OJ&G)JFAW6EW<KE+JV>WFDCPK$,I5B.H!Y/K5G)HW&G8.8AGTVTNM(
M?2[F/SK22'R)$<_>0C!!(]NXK#F\%Q7FG/97VN:S=JWD[)))T5HQ$X==H1 N
M20,L06/KTKH\FC)I6#F,(^$+.6SGANKV]N9KBZANIKJ1D$CM$RL@^5 H4; ,
M!1U/<YIFH>#++4;Z[N&OK^&*[FAN+BVB=!')+$5VL<H6'W%! .#CIGFN@S2Y
MHL',<[#X+LH=0@NEO[\I;WLE]#;%T\N.23?O_@W$'>WWB2.Q'-5-=\)I+X4G
MT&QCNI?MMZ9S<>:BFV9Y?-:3.0< YP%!/0'C)KK<T9HL/F&BW1+/[- 3 BQ^
M6ACQE!C QG(XKGK'P5;VFE2Z3-JNH7NF31/%+:W"P8??G<Q=(E<L22=V[.3D
M\UTF:,T6%<P(/#4MB9KF#5KVZU*18H1=WAC+)"K@E0%C"\@MGC))^\."+^O:
M+%X@TF33IKJYMHI&4NUN4RP!SM.]6!4]P1R.#P36AFB@=S#E\,&YL8X+G6M1
MFF@G6>VNBL"R6[*"/E"Q!""I8$,IX8U6?P1;@:9]FU;4;4Z>K^48_)?=(Y)>
M5A)&P\PDM\P QN;& 372YI<T6"YDW6ASW4-N%UW58)X49&N(6B#2@XSN0QF/
M/ P0H([$9.;NFZ;:Z3IT%A9QE+>! B*22<>Y/)/O5G-&: N+BC%)1F@0NVDV
MT9I<T )MHVTN:,T )MHVTM% 6$VTFVG9HS0 W;1MIU+0%AFWVI-M244!8CV^
MU&P5)10%B/92;!4M%%PL1;*Q]6&+I?\ <'\S6[BL/6/^/M/^N8_F:TAN8UU[
#A__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ([!$<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=W=O8VDMW=
MS)#;Q*6DD<X"@=Z@U35++1--GU#4+A8+:%=SNW^>2:^:?'OQ%OO&=X88]]MI
M,;9BML\L1_&_J?;M]<D@&Y\0?BO<Z^9=,T-I+;3,E))N5DN!_P"RK[=2.OI7
MFBBF@5(HI#'@5*!3%%/ I@/ J4"F**D H >!4JBF**D H >HJ:-&=E55)8D
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M8M+IH#@\IZ>E &Q134=74,IR#3J "BBB@ HHHH **** "BBB@ HHHH ****
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M %/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** &LJNI# $'L:H3V)7+0\C^[Z5HT4 9EO,T+8ZJ>HK25@R
M@@Y!J&:W63YAPW\ZBB=H6*L.* +E%("",BEH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M44 %%%% !1110 44UF51EB /<U$;J/H#N/M0!/142R[CPM2T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %,>,.,'K3Z* (8R4.QNG8U-
M2$!A@T#(X- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3["$16\0X'<GN2>Y/K5/PMX:L_"NC16%HH+?>FE(^:5^Y/\ 0=JW*!!1110
M4444 %%%% !1110 456O+ZWL(O,N90@[#N?H*YB]\2SW1*6H,,73=_$?\/\
M/- '37.H6UIQ+(-W9!R367+K4LI(A4(OJ>36#;)+<2A$5G=N>.<^]=+8Z,L8
M#W)W-_<'0?XT 00)/=-GYG_VB>E:D-F$ +MD^W JP%"*   !Z4I( ))P*
M*, 8'M2UPOB'XL^%M!+Q)=G4+I>/*L_G /N_W1^9/M7EVM_&_P 1Z@Q32X;?
M3(3T(7S9/^^FX_\ '1]: /HB21(HV>1U1%&2S' %<WJ'Q#\):62+G7K,L."L
M+&4C\$S7R_J.KZKK4N_4]1NKM@<CSY"P'T!X%55BH&?0]W\;O"T!*P1:A=>A
MCA"@_P#?3 _I63-\>+0$_9]!G<8X\RX"?R4UXHL53+%[4 >O/\=Y64>7X<53
MGDM>[A_Z *D3XZ,0 _AP>Y%[_P#:Z\B6+VJ9(J /9[?XVZ<Y_P!(T:[C&?\
MEG(K_P \5M6GQ8\+W./,ENK7_KM 3_Z!NKP18O:IUBH ^E[#Q-HFJ8%GJMI*
MQZ()0&_[Y/-:U?*Z1>U;NE^(M;TDJ++4KB-1TC+[D_[Y.10(^BZ*\LTGXIW2
ME4U6R25>!YEO\K?]\G@_F*[S2?$NDZT +*[1I,<Q/\KC\#_3- &O1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5YC\9O&']@^'?[(M)=M]J2E25/*0]&/X]!^/I7I%Q<16EM+
M<SNL<,2%W=NBJ!DFOD3QEXDF\6>*+S59,K&[;($/\$8^Z/ZGW)H&C!HHH'6D
M,<!4JBF 5(HIB' 5,!4:BI0* )$4LP !))P .2:^COAIX)'AC1Q=7D8_M2[4
M&7(_U2]D_J??Z"N#^$'@S^TK\>(+Z+-I:OBW4CAY1W^B_P \>AKWB@04444
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M& ?]X=OY?2NM!# $'(/<4 +1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 >5_&[Q/_97AE-%MW N=2/S@'D0K
MU_,X'TS7SI75?$3Q)_PE'C6^O4DW6T;>1;8.1Y:Y (^IRW_ JY6D-!2@4E.
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MO+)^9#V]Q_GFNFCD65 Z$%2,@B@!]%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<?\3=?_ .$=\":A<QOMN)U^S08X^=^,
MCW"[C^%=A7@'Q\UPW&MZ?HD;GR[6,SR@="[\#\0H_P#'Z /'Z***10#K4@%,
M J0"F(>HJ1130*D44AF_X.\//XG\3V6F+D1NV^=A_#&.6_P^I%?5T,,=O"D,
M*!(XU"HH& H P!7EOP2\.BRT2YUR9,37K&.$D<B)3R?Q8?\ CHKU:F2%%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGH(GU"35IDS';?)%D=7(Y/X#_P!"%>K4 %%%% !1110 4444 %%%% !1110
M4444 %5KR\MM/M7NKN>."",9>21L*O;DU9KD_B3_ ,D\U?\ ZYK_ .AK2;LK
METX\\U%]67?^$V\,?]!_3_\ P(6C_A-O#'_0?T__ ,"%KY;HKF]N^Q[O]DT_
MYG^!]2?\)MX8_P"@_I__ ($+1_PFWAC_ *#^G_\ @0M?+=%'MWV#^R:?\S_
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M[ 4^J6K?\@:^_P"O>3_T$T#2N[&;_P )MX8_Z#VG_P#?]:/^$V\,?]![3_\
MO^M?+E%<OMWV/?\ [*I_S/\  ^H_^$V\,?\ 0>T__O\ K1_PFWAC_H/:?_W_
M %KY<HH]N^P?V53_ )G^!]<6-]:ZE:)=6=Q'<6[YVR1MN4X.#@_4&K5<;\+/
M^2<:5_VV_P#1SUV5=,7=7/#JPY)N*Z,CFEC@A>:5U2-%+,Q/  ZFLS_A*=!_
MZ"]G_P!_A4OB'_D6M4_Z\Y?_ $ UX#3,SWG_ (2G0?\ H+V?_?X4?\)3H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD,T=Q#'-$P:-U#JPZ$'I4E<=\.=5^WZ ;1VS-9MLYZ[#RO\ 4?A78T %%%%
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MC\Q7K7A*[GO?#%C<W,C2S2*VYVZGYC7A5>W^"/\ D3M._P!QO_0C0!T-%%%
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M%% !1110 4444 %%%% !1110 4444 %%%% !5+5O^0-??]>\G_H)J[5+5O\
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MK$9JM4R&D4?0?P)EW>&-2BR?EO-V.PRB_P"%>K5XK\ [K_D.6A/_ #QD4?\
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M'\4;V25$.G6X#$#.\UZ>.E?.=O\ \?,7^^O\Q7T8.@H **** "BBB@ HHHH
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MT'\+_!S>'-'-]>QE=2O0"RL,&).R_7N?P':KIQYF<>,Q"HTF^KV.]1%C0(H
M51@ =J?117<?)GF_Q?\ $)TSPY'I<#XGU!B&([1+][\S@?3->"UV7Q1U8ZIX
MZO%5LQ68%LF.Q7[W_CQ:N-KBJ2YI'U>"I>SHI=7J%%%%9G8%%%+L;9OVG9G&
M['&: )8+R:W@N88VQ'<QB.5?4!@P_514-%% 604444 %?6ND?\@:Q_Z]X_\
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M_7M_[,:]5KRKXI?\ANS_ .O;_P!F- '"4444 %%%% !1110!);_\?,7^^O\
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MT%\(?&0U72AH-[)F\LT_<,QYDB';ZKT^F/0T >H4444""BBB@ HHHH ****
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MKLJ[X?"CX_$?QI^K,WQ#_P BUJG_ %YR_P#H!KP&O?O$/_(M:I_UYR_^@&O
M:HP"BBB@ KU#X5_\@W4/^NR_RKR^O4/A7_R#=0_Z[+_*@#T"LGQ'I8UG0;NR
M !D9-T9/9QR/\/QK6HH ^;V!4D$$$'!!Z@T5TOCK2/[*\2S,BXANOWZ8[$_>
M'YY_#%<U0 4444 %%%% !7O/A;_D5=+_ .O9/Y5X-7O/A;_D5=+_ .O9/Y4
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M#:2!X[5C)<,IR/,Z!?P&<^YQV->6USU97D>WEU)PHW?74****R/1"OK72/\
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M- '24444 9OB'_D6]4_Z\Y?_ $ UX#7OWB'_ )%O5/\ KSE_] -> T %%%%
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M3GZ]/UK?!#*"""#W'>O (C6OI^JW]@1]ENY8AUVAOE/X=* /::*\\LO'&HH
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M_#FB1-N32;('W@4X_2M6B@!D<:1($C144?PJ, 4^BB@ HHHH **** "BBB@
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M%;>OY'G]:[.B@#R^Y^'&IVY)MKFWN%'KE&/X<C]:SI?#.MVIQ)ITY_ZYC?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#+UC0;#6[?RKR$%@/DD7AT^AKS+7/!^
MH:*6E5?M%H.1*@^Z/]H=O\\U[#2$9&#0!X&HJ517IVM>"+#4=TUH!:7!Y.T?
M(Q]QV_#]:X34]"U#1Y-MW 0F<"5>4/X_TX- %%14JBF**D44 ;>C>(KW2"$1
MO-M\\Q.>/P]/Y>U=[I>OV6JJ!$^R;O$_#?AZUY8HJ9"58$'!!SD<$4 >Q45P
M.F>++RUQ'<_Z3$.,L?G'X]_Q_.NNL-9LM0 $,P$G_/-^&'X4 :%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4R2-)4*.JLK#!##(-/HH Y;
M4_!%A=;GLR;64\[1RA_#M^%<G?\ AS4M,+--;EXA_P M(_F7']/QQ7JM% 'C
M2BI5%>F7WA[3-0),MNJR'_EI'\K?_7_'-<_=^"I4RUG<JX[)(-I_/_\ 50!R
MZBIDR,$<$=ZL7&DW]D3Y]K(H'5@,K^8XJ "@#8L?$%_: *9/.C'\,G)_/K70
MVGB:SGPLRM Q[GYE_.N+45,HH ]&BFBG7=%(CKZJV:DKSR)WB8-&[(PZ%3@U
MK6^N7T6 7$H]'&30!UM%8</B)#@2P,/=#FKT6JV<G_+7;_O#% %ZBHTFBD^Y
M(C?1LU)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4[C2[&Z),
MUK$Q/<+@_F*N44 84OA6R;)B>6,^F0PJE)X5G7/E7$;C_:!7_&NJHH XYM!U
M"/I$K@=U<5&=.O4ZVTOX+FNUHH XD03)]Z)QCU7%2!2N,@CZUV5% '(@58B>
M5?N.XQZ$BNFHH Q$EN^,-*?S-6$:]/'S_B,5IT4 4E6\/5L?4BIA'-_%+^0J
M>B@",1D=78_CBG@ =!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 >9>)/C)I_AKQ#>:1-I-U-)
M;,%:1'4 Y4-_6NZ\/ZQ'X@T&RU:*)HH[J,2*C')'UKYD^*G_ "4S6_\ KHG_
M *+6OH3X;?\ ).="_P"O8?S- V=51110(**** "BBB@ HHHH **** "BBB@
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M0 5YEXE^,FG^&O$-YI$VDW4TELP#2(Z@'*@_UKTVOE+XJ_\ )3-:_P"NB?\
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M$^AR 0?Y]LX->E_ SQ?<W37'AJ]E:588_.M&8\JH(#)GTY! ^O;& +'ME(2
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M"006@.T7%RY57(ZA< D_7&/>@9]06.MZ7J6GM?V6H6T]FH)::.0%4 &3N/;
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M--#FNO@NUG+%MNK*RAE*GG8T8&__ ,=#5XU\)M0&G_$C2RS82<O WON4X_\
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MUK_KHG_HM:^@_AK_ ,DYT+_KV'\S0#V/'?CKJ[WGC.#30W[JPMU^7T=_F/\
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M_1:T#1%IOQ,\7Z/IT&GV.K^5:P+MCC^S0M@?4H3WJW_PM_QU_P!!S_R4@_\
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M_P#H:T#>Y\Q^'=(?7_$5AI4;%3=3K&6')5?XC^ S7U_IFFVFD:=!I]C D-M
MNU$48'_ZZ^8_A& ?BAHH(!&9O_1+U]4T R&ZMX[NTFMIEW13(T;CU!&#7QW&
M9?#GBI"^?.TZ]!(''S1O_P#6K[*KY:^+^E?V7\1;\A<1W:K<I[[A\W_CP:@$
M?44;K)&KH058 @CO7S+XN/\ PE_QHEL028I+V.RXYVJF$;^3&O</"6NQO\,-
M/UB5MRV^G[I6)ZF)2&_537B7PAM)-9^)T5[,2S6Z2W<A/<GY?YN#0"&_"&^?
M1_B7!:RG8+E)+60'L<;A^.5 KZ/UB^73-%OK]CQ;6\DQ_P" J3_2OF#Q,K^%
M/BS=SJI46NHBZ50/X2PD ^F"*]R^*^IBS^&FHO&XS=+'"A!ZAF&?_'<T SP#
MP%I9USQ]I-JX+*UR)9,\Y5/G.?KM_6OKFOGSX!Z5]H\1ZCJC#*VMN(ESV9S_
M ((?SKZ!)"J22  ._:@&.I" 001D5XAXX^-DL-U+I_A81XC.U[Z1=V3_ +"G
MC'N>OIWKB8(/B3XO7[5$VMW4+?,KF5HXC_NY(7\J L<MKMLEEX@U*UB&(X;J
M2-1[!B!7U_H=PUYH&G73DEIK:.0D]22H-?'%_;7-EJ-U:WJE;N&5XYE9MQ#@
MX;D9SSFOL#PM_P BEHW_ %XP_P#H H!GA7QZ15\<VC <MIZ$_P#?R0?T%7_@
M7X6M[Z\N_$-W$L@M'$-L&&0),9+?4 KC_>S5+X^?\CQ8_P#8-3_T9)7=_ H
M> I2!C-])^/RK0'0]/KX^\:ZJVM>,]6OV?<)+EUCYS\BG:OZ 5]>3N8K>20
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ML:MNW'VW*!^?H:\R^#7_ "4S3_\ KG-_Z+:@.A[?\4[<W7PTUN, DB))./\
M9D5OZ5X-\);D6WQ-T@L<*YDC/OF-P/UQ7T[JNGQZKH][ITO$=U \+>P8$?UK
MX_MY;SPUXCCE9"EYIUT"R'LZ-T^F10"/LVO*_CY_R(ME_P!A*/\ ]%RUZ%H>
MM67B#2+?4["426\RA@0>5/=3Z$="*\/^.7BJWU+4[70;.59$L6:2X93D>:>
MOU49S_O8ZB@2&? '_D;-2_Z\3_Z,6O:?&?\ R(OB'_L&7/\ Z*:O%O@#_P C
M9J7_ %XG_P!&+7M/C/\ Y$7Q#_V#+G_T4U V?+_@'_D?]!_Z_HO_ $(5]>5\
MA^ ?^1_T'_K^B_\ 0A7UY0#/CSQG_P CUXA_["5S_P"C&KZM\,?\BGHW_7C#
M_P"BUKY2\9_\CUXA_P"PE<_^C&KZM\,?\BGHW_7C#_Z+6@&9?Q)_Y)SKO_7L
M?YBOGKX6?\E,T3_KJ_\ Z+:OH7XD_P#).==_Z]C_ #%?/7PL_P"2F:)_UU?_
M -%M0"V/HOQ];M=> -=B0$M]BD< =]HW?TKYK^'5VME\0]#F<@ W2QY/^WE?
M_9J^LYX$N;>6"5=T<JE'4]P1@U\=:UIEWX7\375@[,ES93G8^,9P<JP^HP10
M"/LJO.?C:?\ BW,WO<Q?S-;_ (,\9:?XOT2&[MYHUNPH%S;;OFB;OQZ>A]/Q
MKRSXW^,K34?LWA[3ITF6&4S73QMD!P"JID>F3D=N.XH$C&^!?_)0)/\ KQD_
M]"2OI.OFSX%_\E D_P"O&3_T)*^DZ!L*RO$W_(J:S_UXS?\ HMJU:RO$W_(J
M:S_UXS?^BVH$?*/@W_D>O#__ &$K;_T:M?8=?'G@W_D>O#__ &$K;_T:M?8=
M V>'_M Z8N-&U54PW[RWD;UZ,H_]#J3]G[42UOK6F,WRH\=P@SW(*L?_ !U:
MZ;XVV'VSX>2S@9-G<QS?0$E/_9Z\P^!VH"T\?_9BP O+62, ]V&'_DIH#H>G
M_&C7)=(\"/;V[[)=0F%L2#@A,%F_/ '_  *O+?@WX5M/$7BB:YOXEFM=/C$G
ME.,J\C$A=P[C@GZ@5WWQ\M))/"FG72C*0WFU@!TW(W/Z8_&N5^ NL06?B#4=
M+F=4>^B1HL\;FC)X^N&)_"@.A]!@   # %?&WBC_ )&W6?\ K^F_]&&OKK6=
M7L]"TFYU*^E$=O;H78DXSZ >I/05\<W]V]_J%S>2 "2XE:5@.@+$F@$?9&B?
M\@'3O^O:/_T$5\D^,K=K7QMKD+ C;?S8SU(WG'Z8KZVT3_D Z=_U[1_^@BOG
M3XU:(VF>/)+P)B#48UF4@<;P-K#ZY /_  *@$?07A:Y%YX3T>Y!'[VRA;CME
M!6A>D"PN"?\ GFW\J\S^"OBJ#4_#"Z'-*HOM/R%0GEXB<@CUQG'MQZUN?%#Q
M5;^&_"%VGG*+^]C:"VCS\QW<%L>@!)SZX'>@1\RZ-_R'=/\ ^OF/_P!"%?:/
M:OB[1?\ D.Z?_P!?,?\ Z$*^T>U V?*/Q4_Y*9K7_71/_1:U]!_#7_DG.A?]
M>P_F:^?/BI_R4S6O^NB?^BUKZ#^&O_).="_Z]A_,T ]CY_\ BS ;?XF:P, !
MVC<8'7,:G_&O>_A;.MQ\-M%=.@A9#]5=E/\ *O-/CYH3Q:KI^O1H?*FC^S2L
M.@=<E<_4$_\ ?%:WP)\3P2Z7<>')Y0MQ%(9[=2?OH?O ?0Y/_ O8T!T/9:^-
MO$]R+SQ9K%RI!$U[-(".F"Y-?5'C3Q)!X5\+WNI2R*LHC*6Z$\O*1\H'KZGV
M!-?,7@K0I/$OC'3M/"%XWE$DYZ@1J<MG\./J10"/JW0;=K3P[IELXP\5K%&1
MCH0@%?)WC3_D>_$'_82N/_1C5]A5\>^-/^1[\0?]A*X_]&-0"/JSPO\ \BEH
MW_7C#_Z *^;/BW T'Q,U?=T<QN#Z@QK_ /7KZ3\+_P#(I:-_UXP_^@"O&_CY
MH+Q:II^O1K^YFC^S2D= ZY9<_4$_]\4 CTKX6SK<?#7177H(63K_ '79?Z5V
M%>,_ CQ/!)IMSX<GD"W$4AGMP3C>A^\!]",_\"]C7HOC/Q)!X5\,7FI2R*LH
M0I;H3R\I!V@?S/L#0(^5_%%RMWXMUFZ7!6:^F<$>[DU]22::_P#PK1]+V_.=
M(-OM''/D[:^9O!6A2>)?&.G:>$+QO*))SU C4Y;/X<?4BOKZ@;/CCPI=K8>+
M]&NG;:D5["S'T7>,_IFOL>OC_P 9Z"_AKQ=J&FE"L<<I:$^L9Y4_E@?7-?1?
MP[\;V?BS0+8-<H-5AC"7,#-ARPXW@=P>M ,=\5Y!'\,M:8@\I&O'O(@_K7B/
MP;_Y*9I__7.;_P!%M7;_ !N\963Z9'X;L;F.>>2427?EMN$:KG"''<M@X[;?
M>N(^#?\ R4S3_P#KG-_Z+:@.A]0UX7^T!I&+C2=91/O(UK(WI@[E_F_Y5[I7
M#_%K2/[7^'>H@+F2TVW2>VP_-_XZ6H$>7Z1XD,/[/VJV9?$J7?V2,9_AD(<_
MIYE:/[/^E;]0U?5F7B.-;9#ZECN;_P!!7\Z\A2_G32Y=.#?Z/+,DS+_M*K ?
MHYKZ5^#FD'2_A[:R.N)+V1[EA['A?_'5'YT#/0****!!7RE\5?\ DIFM?]=$
M_P#1:U]6U\I?%7_DIFM?]=$_]%K0-'T%\-/^2<Z'_P!>X_F:ZNN4^&G_ "3G
M0_\ KW'\S75T",;Q9;M=^#];@506DL9E4'UV''ZXKY7\%3K;>.="E<X47\(8
MYQC+@?UKZ_95=2K %2,$'O7Q[XETB?PMXMO=/RR/:3DQ.>I7[R-^6#0-'V)7
M#_%VY%O\,]5R0&E\N-<]\R+G] :W/"?B*U\4^'+35+9U)D0"5 <F.0#YE/T/
MZ8]:\O\ CQXE@-K9^'+>16F\P7%R%.=@ (53]<DX]AZT".(^#ENTWQ-TUUZ0
MI-(WT\ME_FPKW/XI_P#)--;_ .N2_P#H:UYY\ M!?SM1U^5"%VBT@)'7D,_\
MD'YUZ'\4_P#DFFM_]<E_]#6@;W/!_A%_R5'1OK-_Z)>OJBOE?X1?\E1T;ZS?
M^B7KZHH!A7B'[0.E971]75>F^VD;_P >7_V>O;ZX;XMZ5_:GPZU':N9+7;<I
M[;3\W_CI:@2/--'\0F#]GS5;8/B5+HV: ^CE7/Z%ZVOV?]*VV>KZNR\R.ELA
M]-HW-_Z$OY5XU'JLB>'KC2>?+ENH[GV!577_ -F'Y5].?"S2?[)^'>E1LN))
MT-R_OO.X?^.[1^% V>6?'O2S;>*K#4E7"7=ML8^KH>?_ !UEH^('B ZC\)?!
MT._<UPI9SU):%?+/ZL:[7XZZ7]K\%P7RKE[*Y4D^B/\ *?UV5X%=:G+>Z5IN
MFX8K9^8$ YR7;- 'T'\$-*^P^ Q=LOSWUP\N3UVCY!_Z"3^-7/C#KLNB^ IU
MMWVS7TBVH8'!"D$M^BD?C75^'-,&B^&]-TT 9MK9(V([L!R?Q.:X#X\6LDW@
MFUF0$K#>J7P.@*,,_G@?C0!YG\(?"UMXE\6L]]$LMI8Q><T;#(=\X4$>G4_A
MZ&OIU5"*%4 *!@ =J^=_@5K,%AXJO-/G=4-] !$2>KH<[?Q!/Y5[[JFIVFCZ
M9<:A>S+%;6Z%Y'/H/3W/:@&?)7C7_D>_$'_82N/_ $8U?5?A;_D4M&_Z\8?_
M $ 5\AZM?MJFL7NH.N'NIWF8>A9B?ZU]>>%O^12T;_KQA_\ 0!0#/#/CY_R/
M%C_V#4_]&25WGP)_Y$&7_K^D_P#05K@_CY_R/%C_ -@U/_1DE=Y\"?\ D09?
M^OZ3_P!!6@.AZ7(@EB>-L[6!4X]#7Q:C/8:HK,")+>8$@8R"I_\ K5]JU\F_
M$O17T/Q[J<)0B*>4W,)Q@%'YX^AR/^ T CZNB=9(D=""K $$=ZPO'G_(@Z]_
MUXR_^@FL?X6^*8/$?@^TB,H-]8QB"XC)^;Y1A6^A '/KGTK(^-/BJ#2_"TFB
MQ3*;_4"%* Y*1 Y+'TS@#\3Z4"/"O"7_ ",]G_P/_P! :BCPE_R,]G_P/_T!
MJ*"C[%HHHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^<?B)X&\3ZKX]U:^L=
M%NI[:612DB $-\BC^A%<Q_PK;QE_T+UY_P!\C_&OK6B@=SY*_P"%;>,O^A>O
M/^^1_C7K7P2\-:SX>.N?VOI\UIY_V?R_, &[;YF?RR/SKUNB@+G%_$#X?V?C
M?3T(=;;4K<$07&W((_N/ZK^H/([@^"7_ ,._&OA^^#1Z3?/(I/EW%@#)GW!3
MD?C@U]7T4!<^4_\ A'_B+K0^S3V7B&9#@%;OS50C_@>!7OGPUT35?#O@JVTS
M5TC2>)W*HD@?:K'=@D<9R3TS7844"/._BC\/6\96,-WIY1=5M%*H'.!,F<["
M>Q!R0>G)SUR/#+?0_''AS4'6ST_6[.Y/REK:*0;A]4X8?F*^MZ*!W/G?1?A1
MX@U?3]3UKQ$MP;LVDIM;>:0M/--L.POD\#..#SGKCN?#+P;XGT3Q_IM[?:+=
M06JB19)&48&8V _7%?1%% @KQ[XI_"RYUR\;7=!17O& ^TVQ.WS<#AE[9QP1
MWZ]>OL-% 'R)::#XTLI7M+/3-=MWD.UXXH94#?7&./?IBNYL/@]J=KX'U>]O
M[8RZU/$BVEI&P9HP)%9B3TW$#''09YR>/H*B@=SP[X-^$_$&@>+KRXU72[BT
MMI+%XP\@&"WF(0/K@&O6?%-M->>$=:M;>-I)YK">.-%ZLQC8 ?B36Q10(^9O
M!O@'Q58>,]'N[K0[J*WANXWDD8#"@'DU],T44 ?,'BKP!XLO?%^M75OH5W+!
M/?SR1NH&&4R$@_B#7T;X?@EMO#>EV\R%)8K2)'0]0P0 BM*B@#G/'5C<ZEX'
MU>RLX6GN9K<K'&O5CD<5XI\._ WB?2O'NDWU]HMU!:Q2,7D< !1L8?U KZ.H
MH *\[^)/PTB\91)?6+QV^L1+M#OD),O]UL=QV/X?3T2B@#Y3?X4^-DN?(_L*
M5FSPRRQ[#_P+=@?I6QKOPQD\)?#ZZU759$?4Y)HXTCC.4A4GGGNQ]N/KFOI2
MO(OCWJT<'ANPTI6_?W5SYI /\" _^S,/R- [G&? A&?Q].1C"6$C'/\ OQC^
MM?2%>"?L_P!@SZQK&HE?EB@2 -CKN;<?_0!7O= ,*S=?@EN?#FJ6\*%Y9;25
M$0=2Q0@"M*B@1\P>%O 'BRS\7:+=7&A7<4$-_!)([ 851("3^ %?3]%% &1X
MHTK^W?"VJ:8 "]S;.B9[/C*G_OK%?/'A7P9XQT+Q7IFIGP_>A+>X1GPHR4SA
MN_\ =)KZ>HH R_$&AVGB/0KO2;T$PW";21U4CD,/<$ U\S:]\-_%7AG42$L+
MFYB5LPW=DA<'T/R\J?KCGIGK7U;10!\R:7X.\>^.;J"#57U-+*,C,^I.X5!Z
MJK<L?IWZD4SQ1\+M>M/$=W!HVBW<^G1E1#* #N&T=^_.:^GJ*!W,_0UF70-.
M2XC,4XM8Q)&1RK;1D?@:QO'?@VV\:: ;*1EBNHCOMIR,[&QT/L>_X>E=310(
M^2+_ ,$>+O#NH[3I5^LL;$I<6D;.I]U=.GZ'U%=-X3^&'B/Q5J\=[XCCO+>Q
M4@RO>,PFE _A4-\P^IP /6OI&B@=SYBU'X=^*(/&5U-8:%<FSCOW>!T0!=@D
M^4@>F,5].CI110(^<OB+X&\3ZKX]U6^L-&NI[:5U*2( 0WR*/Z$5[5X$L;G3
M? VD65Y"T%S# %DC;JIR>*Z.B@#)\0:#9>)-$N=*OT+03KC(X*$=&7T(-?.&
MO_#+Q9X7U$R6MI<WD*-NAN[%2Q'N0OS*?T]S7U+10!\H)X:\>>++N*.YL]9N
MV7A9;\N$CZ9^:3@?3K7NWP[^'T'@BPD>5TN-4N !/,H^51_<3OCO[_@ .YHH
M'<*^8/%7@#Q7>^+]:NK;0KN6">_GDC=0,,I<D'\0:^GZ*!&;X?@EM?#>EV\R
M%)8K2)'0]0P0 BH_$&@V7B31+G2K]"T$ZXR."A'1E]"#6M10!\M>(/AAXK\+
MZ@9+6TN+R!&W0W=BI8@>I ^93^GN:JIX:\>>++N*.YL]9NV7A9;\N$CZ9^:3
M@?3K7U?10.YPWP[^'T'@BPD>5TN-4N% GF4?*H_N)WQW]_P '<T44".&^(GP
M]MO&UE')%(+?5+<$0SD95AUV-[=QZ'/J:\,N/A1XU@N?(_L1Y,G"O'*A4_CG
MC\<5]644#N?.5Q\+)_#'@+6-=UYH_MJ1*D%NAW"(LZKN8C@MSCC@>I[9GP94
MM\2K @$A8ILX[?(:]4^-^K1V7@0V!8>=?SHBIGDJAWL?H"%'_ A7 ? >P:X\
M:75Z5S';6; MZ,S #] U 'T75;4%MVTVZ6\(^S&%Q-GILP=WZ9JS7E7QG\9Q
MZ1H3:!:2@WU^N)@IYCA[Y_WNGTS[4"/ --L)=5U:UTZW&9;F98DXZ%CBOLNQ
MLXM/T^WLH!B&WB6)!Z*H '\J\"^!GAEK_P 0S:].F;>P!2(D<&5A_1<_]] U
M]#4#84444""OG+XB^!O$^J^/=5OK#1KJ>VE=2DB $-\BC^A%?1M% '.> [&Y
MTWP-I%E>0M!<PP!9(VZJ<GBNCHHH *\\^)?PWC\96J7EDZ0ZO;KM1GX65/[K
M<?7!_#OD>AT4 ?)8T#QWX7NY(K:QURRD;AFLQ)M?'^TG!_,UK>&_A5XH\3Z@
M)]3AN+"V9MTUS>*1(WT5N23ZG ]^U?3U% [E#1](L]"TJVTW3XA%;6Z;$7O[
MD^Y.2:QOB'I]WJG@+5K*Q@>>YFC4)&G5CO4_XUU%% CYV^&G@CQ-I'Q"TN^U
M#1KFWM8C+YDK@!1F)U'ZD5]$T44 %5KZTCU#3[FRF&8KB)HG^C @_P ZLT4
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45761111150496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 27,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los
  Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">445-2800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<F]P<R]A<' N>&UL4$L! A0#%     @ ;'EE6D_P\%+N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ;'EE
M6IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !L>65:$\44+D$$  !S$   &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ;'EE
M6I^@&_"Q @  X@P   T              ( !A P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " !L>65:EXJ[',     3 @  "P              @ %@#P
M7W)E;',O+G)E;'-02P$"% ,4    " !L>65:JL0B%C,!   B @  #P
M        @ %)$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ;'EE6B0>
MFZ*M    ^ $  !H              ( !J1$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ ;'EE6F60>9(9 0  SP,  !,
M     ( !CA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&V!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="radnet_8k.htm">radnet_8k.htm</File>
    <File>rdnt-20250227.xsd</File>
    <File>rdnt-20250227_lab.xml</File>
    <File>rdnt-20250227_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "radnet_8k.htm": {
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20250227",
   "dts": {
    "inline": {
     "local": [
      "radnet_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20250227.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20250227_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20250227_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://radnet.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001683168-25-001349-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-001349-xbrl.zip
M4$L#!!0    ( &QY95H&Z6"&?!0  '^.   -    <F%D;F5T7SAK+FAT;>T=
M:UOB.OH[OR++[NQQGA5H"\A%91\$=!@5'< 99[[X]!*@8VDQ;07\]?LF;:$W
MY*JC9_6<46F3-\E[OR3QZ+^3H88>,3%50S_^BT]S?R&LRX:BZOWCOZJ=6K/Y
MUW\KB:.!!<V@J6X>)P>6-2IG,N/Q.#W.I@W2S_"E4BDSH6V23J/R)+:=P'%\
MYO;RHB,/\%!,J;IIB;J,9YTT5;]?#)^^G365B*8&FM(GWB#93 0TO%7F'?R-
M#S+.RT!3*[9IWFEJ>4U5T\@)?.&Y>3@M9ATFB]KR=,ZP0GQ[TKZ8-[?BV\^;
M9BPBZF;/($/1 A)22/D4)Z2$ Q^0E(GE "#XG.X;CTOA%%-9WH,3(4YPI?2U
M))HSC"LXA&YO3'@!/82<U] V4WU1',T:]T138F#=%^'&Q-"P&=N:O0DTEPU;
MM\@T?B+NRT 'DUA1T/ PT*A=;W5GK8BHZ-A*R\:0MLES@E!(4H'!HE))(/IU
M9*F6ABMM46EA:Q\U=3F-BJGSHXSS/'$TQ):(*+@4?K#5Q^-DS= MK%NI[G0$
M^)2=3\=)"T^L#).R#/3*.$,<_2.50J<JUI0RZF#K$+7$(2ZCB3(Y1,TZ^^6.
M$^IW-YU/0OVL6KV&'W0Q*)5:L7,V=T=7?#=?Z9VWTM6!Y*JS3AOTSI?N,/ -
M3!W^KPZQKL _ZU03^W<]43/Q&I!J/D@-'4@PK0$H(FI-7<&3<SR]X^"K4.+R
MPL'J8 ]. ,'U._[.%7@'/CQ: X1PUQF(!)MWPAU3;PX,DSU; PPE=?W:!96-
M3&@1;,E0ILBTIAH^3O: X\J(YT86ZJI#:-'"8]0VAJ*^[SS8A_&)VJ.,KJB/
M7C=%-4>:."TCW= Q?:=.RI1),0%)8!]41<$Z%0OZ"5JU["' D1T6GUAMW#M.
M5LVK'N40IL5 <ZK*<?)4E"U*%BZ;1#HL&L;":CG ",D*XX2C3 #R-F/E_&/%
MLDJR,N>5N($S_C73:1#<PP3L*S;9>ZHSRR8SAC =Q"Q<>4#HS(@"\N\)2GIB
M*DGWM04ZX3AIJL.1AJD><(<)0':&,@V;N"-!(T;VLKMXMM#0XEUMY;7$;,'>
MP]EC5:$O>BHFB$T<Q]J56O,\B)MPY]E@F;C1W+%&@$A#B4P!+#NQZJ*%*_/9
M>W#F[\*]@%46]/'>A*;D']U[YJ(O@%);5QU\@G"%D3C$HFD37'&%L Q-/%#>
MJP!\"BL>N"//B^"[BV=M-AQ@KC3"@X"$ ^$B"*4]&;.+ED'F;]=>>WAZ,3!]
M(]:Q;@Q5?<F82_$1'C0&K/?:O_PP&EW1FTN:(_*NSCO*0-]*(I$X&JVK60_1
M4"1]52\CVI1+5HXRHTH4D&1HRAK04I8Q8A!G#R3#LHRA^XRR=DK4U#X,*X-$
M8C(;UV=YVK:&4]=BGQE=O_H/@<Q2D&-5L09TP=RG9*"Q9!# D3.A$TV4[Y$
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M,WJ:&> 53(%$YF/W,GC"OZ%22:D8UBLD99>?%OP<.]V^-C3,Y_>D\SR\MTT
MRM#0==O[$()5C+?@S248^K']J6M[<&@7]G"D6<\A"AA6S\'3U8FLEBIO8&]$
M(W\+/#*?B2,0QNZ3U^5:K22?GL!TIF%;\"+Q!@R S#'/?P,?1.0C?<<>PBN*
M5"J3-&^H'\(5\5?QP4OCP< E?V.:"2\X'->U>Y,1EST,F>6=GIP9B-JN\<AP
M',." ?W?X'$^W-O(#I5Z2>8[?"W72XU4ZPIV(I=+M<4OG)[X._GXKOUIZMS>
M=>\XMJ3 I_ V^.>]X.,*HQXNELXA3D10IR?-34;6TY/7M4I)2GG",$H/YW-@
MGB<#'GA=K93JZ="6 H4,,0R_!$21WGP(</?T9"[R+B&\$ZRMRJ6JP-IRJ;(2
MTBJ379R>+-Q&@;.;X*PX2>2O?=LA8VOLC@&'X4_;8N<>/$T,CPU=8@"2]?AS
MR+N!*]OXDS@7_T#HZ<D$+S3'@H==<@L'U1D ?@H<4:/X_QJVKO!YYZ/#!](=
M&"&2NP+)4TPC9N&$#::1*XNG44F!19M@47O1C08Z\_#@L ?-8V3DV#VFCQW
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MRH)1!#/"R'P^SP&^CE9>6/'4W-? ,+CRS*<G_NS(E04+!V[H^>NP?-X<:G7
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M3J*A\F8Q2()9*F_FD*W7,JU6I'/XIR9)PV&6T]0J?!JEDNTT=3&-FNTT-5D
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MGFV)-CN\88M%PAYI09.:%GYQ8>-_1>>>7YH;[5RC8;LPTR18%Q0[4&%?L]'
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M&/\?5W02[-LH=H191[AR3!$Z!U'9SZ5RCX3E?6S'\/R2>9IA8A90^UCP&T3
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M+[I_ RUKX4&42'N(=670<Q9X.#G,>GP*<8YVXL9)TK[Q1FUKW_.(E'@+J]W
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M E_Y'U_Q-(1K'$0% \.!_-]=0&VF<V\37 94, N]?\ODR.X);M+CU!_3 'P
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MI1;T8[%,4E:VE/!X5"X;F39J1?S87)RA4BT3%^B!BK'-WM\@M!K<9! (JE9
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M*J_];B4!\W>)[O\^=[2UK4^;('PU8F58_=W*!N_6\H+M/TS/T5Q\>NV[JVX
M"7AY_?LB*YO0*V7?9F=M.+0?'&TT6!OWY>IF!'M]DB%O<G6 SZ@YP?_YLU^/
M>R9HF(1[!PQK;5^-M,D1;0!D:0-V+"7(AKFRZ._#H*\D<,G=S!MG%KN85TU
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M*#D"F'-ZXA^(6!@#L P-2ZQ)Z_6 "O#Q>#TDCJ\^NN#>!(UWQVZ/C3P#932
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MI_P'X]UX,;X:5^HVQ2W$?K-!R1K9P'59KQ#+D4_%;Y=EU?A%TQ>=OD,N?V*
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MRTT+*V6M#7'N%%_+,S<<LN?93V">6O.TE?5=B)+,172U%C9.I*<\B[)N-8M
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M+=54P,EIGZFPA0^HN(W ATQ ",?@J'=05'7#N+NV$$,OLZCTYGN;HS >1[[
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M4>QIC-!_E&?(SNC8ZR(\6Y%FZNE'YQ=;$[ZU_:J4Q0%;1#/;HT>F'G9\^<H
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MGE#;HQH)]9HPHW0$Y<UV,( ;]/J0MR0=;(TDN@;Y\1W9]V!>PV!&K27BX7A
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MF4*";A;3=$;(O1\:T08-;>\?FO05/H^BO>?2H@V=:UWVZ..L%9?B#-K;:S?
M<!E$/ -DX S_2F" S!3*,Y!:U5.%G8X*W$,+?7%'=87 U$A;5X$,P R66HTF
MYX-!).ZA8:AV.>)4T.P><<V1#Q'%<!ACMK (J=& '"+ @.?,MNZL[R+\!]7R
M[8;M.;O0[L)-;(>W(>13K"'RR4<%0%,#H.1E0J^F@;*;:.:X7<1"&>R)V"T[
MM&(9ZN9_BPY3=]4!'69>Y, HI/0S-)BN"ADM@\]TXL/E\7B/M?HC*'7=#M)I
MB]H 5-)V!/.(]CD]6?I2>X0/J^_*1SB+$E;DL:I\XJN87(VC']JW=:<-1GJL
M7(+7&&%!?T^Z&IK<-=1?ZE88>^B&(#/;<!\]O!_L :7(63:R7YN>S8:3YK=Q
M3UX#!I-/)'$S=JZ\1!<8.V-GD8"G4CX0Q;+7=IP;Z4/35_0VX%7D]>!NL.":
M+3:N!I!K;8@['DJ ![M6%4[4%Y?>;_7D9)DV1T>KK0W&'WP:HU@=N1-4#X>-
M>@/9CISBFRT4#45$%VXUY-K18 $/E+O]5]ES?1<%&!=M,?1&)NX..@P2:;4S
MZ;L&^,X-8@1V/$5YDE<YJ"[M>JX QG;KS*(\/6G01AIZVP3>]N92EJ#4T#D?
M=S@>C:2^QY%OB3NQ;R?8Q0<2\J]B1+!OG(9=>.X81\# Q3+00SS5WI_@N6RW
MX%\X)']6WBVCPS2=DS2R*C6F 6?Y7IN@J$-;'W5]B"]6,_<,!'B^\DOQF)BY
MS/VVK/>J=Q)>K9L9[0(/5]R:!K(TZ-]Y=F$=CT1+#+!O1*,(SZY#!%V=1:4'
MHMM$9B7/XH!%:#04V=04&PRZGV59[Y1<%UC$@HV,$A1V(RX-JSX6XFNVUZHK
M"(P4)0OFJAPL$0[]ZJ%O']Y_^$EH[P1/2ZEY(QT9V+$'[*2H*V0/2 4XBVS#
M<MK<8[\AHT-*:(4*(^A1QD#2K%' X5ZC:)A-3ZNX4TM4Y+W2OP6+4?T9%$%H
M&S\]>1B[0YZAT.4UM#'SFZV<&& /X4/I36-Y!"^+JOB]BR0 UB\KLB0Q<.A]
M'#FE*9)5R_[S6-$+I^P81[Y;[X1*H2M%QSKPQS 4HB2RT:@*-1>'=E3POH P
M!LLTC:_8,[[2DB9=C@FO(&N8YCZIZ,*2D+61*Z\E@P&=1PF3VBFTH.1O;7.@
MVT:36/Q4*T?44&BQ%]54<(' BW98Y-U491@-E+B-&:C2NJU0_L/Z)U-#K"/0
M57M J1G8N*;U>#OL\$;A.6K/ITSM=D"$54>N,G'[*[:D@[-OO?_2XT&O5C2-
M5BN3J#(&:]Q"K$:#]E,=&>+\]"0$D@(;6KAYL%M'JS_:ZB%,)_I;/'P< ;]P
M1UVQ\Z*W^D 1H6(LP(]8YP)2W_IJVR'#0B4X#5CAQEZ*2@@7W06D04@GM*OE
M>*ERQQU"]KVY;!<Y.W](7!-5Y4.5%%^[\5N<DKGN1K42$%)!44PX^BWALBZ6
MW:@!B=O).<*[C&WZ&W#\\7!/OHLDJ*%1+;E]&2 9W!&47)6P%/QU<CFFAIZ]
M^MO+Y]IQ4W6!T0HF!>/WC#55@YJ+M?S;5ZNAG2$K3E#X+(?L"JJP+MM4*%1P
M1']N5<N\[-S^P*O1$;([C%8$JR&,LJZ 2C2#+5Y-"\XOUE6\8E!L<AJW=57Y
MTLHQ=;T,2K-H#SL5R";MV9/%5=H"07L74@=;"8<9/TKKEP1,9R,32 .\K'M+
M:L_@?DT:[]^X6=^#^Q-:ZZZ@M1[<G^!:$UQK@FO=7;C6<;?K4PZ/-,&NKF0P
ML@VRPUB&;9W_.G]SGEE#9G+)1S+F=PX^7BQ%7;DKI?%FJE5=S$=/DEC^-2,3
M>!S+0+?6[HA%]K)OR-L=XO2!VUN)Y9MZ-_2Q@_V$'+5\\?ACQNLM2C9WQDV\
MK;>]LA)9WEK,UU6@]Q?;WC=B'FXMKH)<88C/10MO'\Q*W?^!^#E/.C7+Y1<O
M+<B=>)V1XAH1[RWCV3+A/=B5Y)W)VRQ&/_L9LM@0'1 .&9JSZQ;CT"W+R/;G
MVKN\8& (\<&(<J!J4P_'O#)%3W&,2 <$)HY2N:==Q9$1LSV60+,9  (#9[&[
M=D9;&E$I*SGF',38?63S/C!-@TD:N=#A5R5C++>J=RU+Q6NTB9A,UELJ5TF2
M*:&O^B(T"M0G !+"YNI, ]%7T>N&J(I.."* )%YAOJS.DPMB-"E^'MP9\(4S
MW'G@309/D[L&T ^9==\B?@IXT.%*3S-T2,W)?U+)(OW\;$Q3;JU0\(CH_XDP
MP0$D13D<8/IND=*=<2GW'BZ:>'E'MQ-60A+!@GFRJHJN5W[_W?68@4&3P)T6
M%2\+]X>V J:'8^S:AE;C6I0H;E",M";:X.@9SQ=M$AO>)"P2 R(CEQ]Q>0A$
M3O[1W8CAJ45#AF@Z_&_C]X!^*EK6,X$%I$!7U+>J)G>VP\$;8RIG1"OF4Z5#
M3N99:-=COS=2D&Q>K,@<%@)Z82 0P:]%MW3&T;!;UP!GC267V2(F:,1 3^*&
M&),X'\&$[@5B-5D@&]B+B)KC.62V&P4CU7'OXA(,8<F!D"B$44'-0CUK"0$1
MU;9?7K/MERK#5C3FJ"6*K1:0*=ER"9<V;EOD(L2D(6\IC'D].5*G/9I:S*PL
M,-U#I:]RBX&Y<J\))J9.N!L)4@NM9F+8;8NLNG&9N-A04OZY=N42-#DRX7KF
MDA\G4(7L:@+K&%L7_:PL*<#_^8UL'E/1"*QK^&FIJ@%-YEQ?D?DQ]*;T,GZ5
M>3\/[S]\/+L!-R';&7  \;:&[ET#_D[-,X,B&L\CB9<8%#O,037%%4*+H<N0
MA@:O_'AX8JLB]ED*VL^ZC[3*,OC@/B;CP1,#3[;&OD8B-O"ZB]WF>@5_!8=2
M:5*@5K&+F)Q(S;0W@7 PO.YAEN ]HX)6N>22YS[7*'?<[.IB7M<0 S=6B"VF
MW%1R.W0629234G#*^5&S!=>U6.RR[Q2[>Q$BKOH)#B%5FL!&*(/-]7ZH08"=
M*[K Y84(H_Q%'APT>9&QTG9F)4(9U92]F\!G1R[D2[IOQL:BT-UQA8N")G:U
M\A.B+Z?8-&?]MC7@4F7P-#G^F5.=:1CO*ZB8:X"U_1BTK=NM6&+':1)RJ'09
MFK5W?BO/4U1YBFW2Y.W0V) ;%#=7U"B!#Z)=/GHT1L2]>/KR[?,+HIP?//GX
MK&C7YMF*.=-:.I\:B4C]I' F8 .2]V'F'H+._;ZN<@.F;?9#*];1F$'1Z'BF
M?9LN7@8T1RSO 9H>K]2N71/L&N33^A3_PK05__[/QY.:^0 5,]FD9&Y'R)\9
MH/G6]$47FT\&8K816BMB3P/_Z4=BP%S;OYFA9:(R801%MP<-EL,^9K ^0MPL
M6C&A+TVL#N&N_NC1_1LU1JS04!?+V%O-:3SX$K(%]MC0W1RP==V^<MG@1IV>
M6+4*M[F[UDIH FM.)L0Q"_G,#C*QJ^-)%H^I_WP\+=_I:#I>(?5H>G:#+78S
M<?K@^*KA185MQ\8GY_&@.L^^\XC$JKF79HLTEVH.+D(#JUI-V<F$F]3\,0OY
MD[4*9@2G@-VVU :,4$S3XIV$/"(A?P<9UX,'$[[KSN"['DSXK@G?->&[[BZ^
MZ__L4V=RTCZDDT9V$^OAG?I:T&KR]Z=IR.X&QXV=5_I&_F6A\\EFG1RN8Q:2
M!<^$FYYGS^IJ)2=_F[F5*ZIIY4[\:$<K)'I_L(0.Y?K32IV()HY72*64D%$E
MP\21"WLG1G1JFO#?T32!P!F%\Z+B6PLEOJW75?9:?@BN"8!%7KO]!CGD;]UF
M:I_PP98[AOWT1,=]6O(?@ !HJ&(XSRY(!<I^I%Z39H92*Y:'T*P;/,"0FR9&
MC'>Y]_#)C!QGP)L$%F/6C+/G8@'[>[@=NO=YU@*A)6!=*>V:TMF@Z^JB[-E$
M>6#]F7+?DZ%^M$+^#)PABX42FJI7;Z8U.QT,QRJD!@(!E/MCT_[:UU^@&(]T
MSC2!DG4L9T;;:S'5C9<&5ERM16N[?KF<%OZ_I[(6D</0'KVLL@%FIR<MRE@R
M\L8.K/%#MW!6-(?4'KC=68^I&*7/$E:S.OOH\_L#8HG8]6C.*"!6;QG+8*Q2
M.YH_IR>AIO#P<1\]?#)ZT*/AN2ZTC1@S-H<[M?6RV[EF5 E.-*U6C4;B()F"
MME^LR17[1L:\^QXMZGGWMW+1=\74!W$ZRHY7R.>U,DD,FW915T!OA.))@N)+
MOW*+_; G%F5!KT,N3[E% W'R=(1-0AZ1D+\'AO5P@F'=&1C6PPF&-<&P)AC6
M!,,Z2B&G=.D'$O*;XO0$KL!Y!C>4'8 FHJG)Q3I:(8%$F=;GI%&/5TC45#'N
MU?95ZS6^1JJD##U88:YI(>VN!EM@*\;CF.*<3&QBD=;5V;;Q&W#JH+ ]9<(2
M">7^ T\8R]8MU+8I5MJ31!G/C?4'T3TT<376G$59]_EL3)D&B@Z'GI&@/DN8
MQ7AM5CD2';9&%9^008V8(I/0(=OCXK= .G3H4@)>)S2)5!9O=IBSB/WC^_<#
ME7H6>C/H<\.8I;G8-(BBM/I&@NXUV<M:?*V_?Y/R5IV>V*\6,L?U!@^+]&FQ
M.0@H,AEZT8ZXY&2T*9CTSFU!7Q(FA#AA@>W>VLUH:X+WYOTC"96V8R7)5V!S
M6M8RP;J.&J\(@I5LLE<56:$626F[<NZ;-(6R-"A)'E?[Q<M $.&,?H_LK&T[
M;GT061B-H'ZQ9L2<_1?1$ <;(2QN JFP\#<@#T3:2O<IZ;-&K&1P!JWMF7)'
M8J>!C4<;3AO]E7)18!63U"]XF^?94QLWX^ O?/ X"Z4[%<GB2P1.+K2K*\3Q
M+_?Q&P I4D[&H9>!WBJVDM6>1 >T8_*V:[=M62Q-HL?0%4WU43&,HS$ LJ6%
M\GFU;(71*O'/C;1KVDEV9NP<&R0.3"<MG+(ZLA6W,JR!8FCH\QJ9-@-KB/9<
M@BI5!);2Z[(STMS'](E^R])O-HD(O3K(31;([<)+L<G;7A;32K^/;5_C.8"U
MBNJ%@6@ST\Z9RJ,9FW0H:"4LW-)@8L2T: .$J,BAK4+V"'H\,LY:2*+I;7V)
M&$'>66@I6N^,_VSN"4%C7PGO<'39L)F4&Z:)?H,0E&@>I&[D+-JN]S.P739R
MUO5XD/SOW5DSF7&WQ?45Z#HC_W1*/QTIMP)_YV+HU@6: YO8\,NX1DMTE>_B
M7K;+7CW]TU]__N%%8(]5^K_8C4661-+R,*S><,1N^Z;ML?9TN]JQK*2HNMY'
MA['%M>P-W$@;!+4R:NZD6M^ZSA21ZH%\MBI^T:0+./;01@<IEU]A:/*H&%2B
ML^Q[Z\O]_6LY"YZ]G64_OGC+_^I+%E6ZSBGJL-25'_'_Q5I/R!ZIIUJ2R&KC
MNGK;C=_D?;N*(XI.8W9Z#$.H;WES-QX')LV@@ >.0Y;\JXT6V*G?;1'A;G7$
MJ5U(QGBP\?%(=EDC4WB@_*VBSG/HWC<TS**4+8]AD6/H;@2%5%G7.N6^CHV!
M#^;?UEYL+4R*SX2(/'0)SQ)[-^:LX]M%3:\- '<^1'\G-?3O"1&Y$^.*$-(,
M[+/DG F\O(O2R;?[A- 4_9E\T:EA%C\^SUX:4,HX:;C1Z&MRRXKYJ?MY8YJ?
M9A8K)T3C7EIG,KGSRC4Y^^4&M C-S/>699H%,NVLV_*7W@-Z-LT8:"-QGG_T
MX+/SSP,L1T]H0''0FB%,'5T!7GNMP%9F_X8;!&-!SK/LT8/SSS\.5K\\/U)?
MQCL3BE>BJSQ<\'OM5*$[!9?OR+#^WR\KU^?%O/3_S[1,)ZO@:(6,3I]8L24\
M@7W=SS)-X_WDK>7R&D3Y*#0_\I>Y$R,^"?F_ S_V:,*/W1G\V*,)/S;AQR;\
MV(0?.THA)X?IP]"$.^N=26,3,>%Z-]4K3)[3T0J)8M,C%_%.C..D3S]X .KT
MY&=1K*M^WVKR4+L! R>QU3Z154&33Y$.C2M:"(FD?SV_TBYL,TMP5GX_0"$"
M)49;=*&Y)BI/?PJ0!8)&\MS2B6Q<M&N*CL]>>W&BD&H+T>*%:]<#WFJ&#HXX
M#AB=F Z"Z2 X6B%_\F4Y&]HZQD6/'0 LUDP16>N"H*8QDJ%G+VKFP(=]H-L0
M^3+QW![>?_CD/+MHK8]:UKJ"T"-V&BYK_AY5TLUER$??>+?8E+AO+1=G7N%!
M/JCU*V;FB1,#@DJAC+:%]2Y&LCIGY]I><8VQLR2R/"%!?GHB=\&W:3.S%) 4
M()ZA(>P!CI1UW;MJZ/4)E80O9/I\ [A:A%_2ZXU"4[(!1&5MVUPI[EAN  HG
M6FM5 1R!3&BX#SN;'P#)6(P>P%5;7_F.WOD<;=P45T<DEKS!LBZ+&D.?%-^F
M P.THD$'T'72:NH[;1>E8V'MHM#8MJT;+!X<CO;IZ$KM*9S.T8PH!1&F!:!&
M(8@5?/+2/L7W851D;L;X-8WS$+TVV36377.L0G[C "Z%94 3Q&6E&!\E@EG-
MMBF(ZE)LDZ(9(IZWC2&SXN\#>',!Q%;8 5'-6$]=LW)DTP [U0#$UJE1@E_[
M9M,2N3@O\C/77D(!L<$Q (MHR4W;JE$@!%6._'(R9*9ZD^,5\F=6-BSJS::O
MK Y#.Q\7[;#1^FI1(D03VT6'=&$P@%[*)>CB+0=ZCB2BX88:_\<USLNC'X4[
M,563,?^!\N&1#TQ[QI-F9;PCYH8/)3!W,I4FA7Z\0FJ%%&LE1FMX6K6W YW)
M:\!C H"&]93!#*7/SC[%J D .Y/X9(:8#?G6TF&Q,R<,) %HL35L(+>X@H_I
MQ;GK]N*4+BX!N]0BB9S50(YUBOM[@.0#%\^Z2R?G\Z@_N=QHX;4T+=)#%RC.
M%Z/T7GMXX5?9RR7J-?/:MWBQI?Q;3%TB=QG^$]>W6!Q4$U'@Z,$3V0O.MLZ9
MB8W^\;7<'N^#+LRH#-4H@18T)85;XECG=&5ILQOU%4&@K X=N;H[:YZY=2V,
M?G5F-]/"GH0\(B%_#T+I\810NC,(I<<30FE"*$T(I0FA=)1"/NU9E0ASU"U0
M]X@R[[IAU28(=A,K=%1$.9-S1$MQ;D@,:?D/OWEI\=(W(9F1,"B0XN#EP (@
M8EBV KN0Q:*1BP&%P;$>7$DV0#6 ])A5I\V-S:!ERF55+ :.DN&*55V+,=EY
M.)"LU5W7.URB9:-(D[EVK06T)$29^P[/'>I7+[W?RJCP/LQ"SUU)I:,\"$@9
MP:BMK[R:F2BKSV54;C*$1:DU'F.>IK+(*$Z"A0JEN.*2(39&!@9-:>D%95VM
MSA!7SI9]US?Z?*N/&GXQ!-K$N[#!!6:*2H\%R$9TX>S&?3M$N\EP;N53$WQE
M2O,<K9 7I6P3&FI GJ /%PB#4/ ^K=HI?'RT0FK+N)D1(1ZYL'=B1*?8\(=:
MJNY2[+.%&"W3.IU:&QZCD#>T-@295*MF[465-R+5]_6E!JB?NF91NOW4RO!#
M+6\=\-,3&?%IA=\69?+YZ0G:&6;6S1#.'5Q;)3!:ULJDMK7TAGC,<]*S#'!/
MII@0ZQJYA88255ZNOBJ+2Q+QR8:8(VQG[J!ZF>=9++V)(;YL+K^E,[FH2P Q
M07NW+#5TUC6^RIG;8L++>Z,69(9(!//=5]E/ #;F(@.%4<JF@?"/6:CDEE\!
MW)HM78-4ECC!(^PW_&NFF"KSYO>+TG^5O9T:2$\FUI$+&;T!59W#%MV!>!=!
MF#SL'^4BV]6,@[696TW4Z9.?>[Q"OB:L5E:V:.5GK_[V\CEIPX@D<$M$5_GA
MM(0G[7R\0EY@H9Z>Z$H%O7?@CD;@?N##ZQ0JTU>*1P&R)ZIQA79O413"[ CO
MA8 E>"1G,+B45'<HR?&@="Y+7ZT2W M+0V(?:UH[2[<PLVK-_ O\=.8*0'1=
M+/K2-6+1&7)]%@BGY5<6^><3M[X&"!T_-7*UIMXEUEI7[SQSJ,0165W/Z0D2
M&$PGR%%4%D@4-0%K9,E5)F5H'[8R)BBBL:R#$K*2K#-D:)!Y4AI0L?'(6,I/
M0L/(X<*\EI'%4"MF__1D(?_ $>F2UMJ;0FQ/KX2E7;WR+,K1LL.7:NZ*$3MW
M\W)_,(7\+E0 M<5FX_F*$&PN9S-',2 [#Z:(62R9Q;7+U?4<3'&U=SG"5FG0
M^&7)90+J8Q>91I$QV@P,>%XK IB5UCG$-'"AQ2'DFY1^8ZGYJEB2=UIT;M?Z
M<CEPH[(3IMZ09,NQJM*;;I:#KZB-ML_$P#T' F[Y+A1U#4+G7MQI/U1S97 C
M8ED$E@ERA[A  _/CI8E7:T22HI)%(C/IR7U+TO-<O X% 43*/V/)QB7I.'&1
MI@2MME^:0+G*Y@00*:P56]DD2U^&5-^OO>B,3E:LSPO95E/ :Q+RF(3\/2BQ
M)Q-*[,Z@Q)Y,*+$))3:AQ":4V%$*R>P*W1/%0M&X*MI#LSGX.C2R7 \/?_!4
M4 -O!0_TH+3A%*S0>5&Y0.O=]MMMJ1T-U+B;V;;EQ_52V]:H02V2++0)R<I\
M%?Q,E 5:OZ_%9+\,GR7&[!!8U@BZ2HR:@<8OZE55# 3C&F4[VY9].X3:Z!L$
MKX-.7=X [=5KG?Y-<+@!.+<G42K4&:2F%;Z2+3 4]K. DA7)-L[J94(\.7C[
M+C2]CY,@RD>4XBQQ">^UPZ7PE+SQ0R2>B&C-B2;]5H3\FIV4L(K%.1EP=[/@
M>;C*E?N_QZ"M=KQ1EU\)%:I<1! '&2Z6N'-UZ0>GM$ 'HUT&V@[Y.,>B:JU+
M&*>R[1):'BY0QM@,!8C-Y,#8CZ'030'^=G7% 9/B DHX),1!YDFI;!?JO2(@
M:I>0XJ=OM+X=?!J!T5_9>V(/$)D!.JDH#JZZIBXCOTC<'Q#A_'Q:@%/0^FB%
M_,FS6L[,R&O;$'H<89Y6NWS9)@Z)S2(_8Z]!\0K(DI+\<#:.?"3D.NNZ)?T.
MHCJR3=!44#'+L7@>BL8*ZTM03Z!_G)C VIN+?8@0G!G=7VE=Y*7KYDST"HKT
MK+BSVY^!OR8?GGO8=&[C?JD;A$+,4EX;ZP]['X+.0B-@$R;HMLG50_S0A9@4
M6R05]%%<PPI=/<>IQ=F3*?27TY4(!PCG! *?XV_VNC[*?0S>!0OHM<M_\.$X
MH PL657N-WDRHW?JO"$63/S\QM'"TI_*A=O2H<<'31F+)Z>1W7-Q>).UB0).
MQ.J*MM,USX D?SP?.CF=GI0,9NY+4DLD1$Q\"8X/Q^%@&\WLK]Y.*!Y[VP91
MO0[^VRR&J15[;][?A98,&.U3U_B-;,2ZQ][;R,@S6+IU<H(/048'X(7::*-7
MDK>&MXF@-XED8B1]O_6L/6CE+=0FV-0YHHZQOC66 PRA='1%^[4OMEM$==G(
MM,I+:YM*=J<A2,X5X:M?ZKV\,*HZF!Z JJ'A/226?VNAQ;4U[>[;*K.1144&
M-^!MK+6CJG\LG55?Y(A+H.,LB=QFAVT^61C3ULV<1AI3*!\]?I)VTJ&]AUU1
M^65A_&H[^+Y%A9AWZ^V!T-W#$WF6:93\%[^@"7COX9.PGA@,\4,RXEYH*&=9
MI[$]VK)HNS1W:=344I=JPGR'K(!<FGA'H<XFN&S656TX7UOM6V?\D<E.,H>G
MM;R%^5_QX]0^M9YRP35<DR/*/@R%\Y;'BT.OZJ!"Z3JR9C9ED0/*TCGR\;V'
MGVB:R._1VQ6*$^IDY4.13<\+T?00U'FAU57! !D9HE293ION=B U,HO B;5U
M8#%8%5?&1-@B#;5"*H@Q0!G_:MSN.MUX<C$:\,KT898#EQ]FNBP6OFIM1;8W
MKKU:N\^*).%<LX([4#'H+F*,PVV\NN;MZ)B?UL*$23U2(?]:=T@QGV<OC1_$
M[)^]&:AB;\EZ!IU):+.--;_H&^;GFP1?&L"@KYH Z.2NI>(5JZ3&79@S6.];
M]"BM:%L5>3"99)=KO_F-XD6#&1C<E8E,;PHV'*V02KTT6L\!,AVJ==7>(]H'
M<;FPO,V''_;=2@Z.K>:@,B>GF[<SC#@:C1JGH89B.?X@BO%W.E^;U!,C% 91
M>&WTM4$G7U\QE*E<W_,]6\*'AK\&2Q'GK25-SQF%0@MVN;KJ4LLGAAA,CG/@
MU_3!\, 09YR-+F!6KAA.8>23S78-CR86A$3"\9'327H;@0IS'X8^[F'$Z7<B
MO "3=Q,:/>O:L**$&R8E6OM1M1NO%=RD!)ZT*NNY_ ZS3E="-7[C%UY-.K W
MB[] 2YS^B"PZY$+6I-.2A0ZGVN''=L-T;2;B7'^<>,UQ;YJI+_?$'G#;K=A_
M""?$+K4B\=:))U]UT6^9EMUDP!VID-& ,T#AVI=;<7*,;5RS1@3>@9 "*&XH
M?ZVW 3>'7A!(),2%$9V^8#X8"3&ZYC]>/'O#+?[ZY1MDN0JQ^SS8/.@8#>3G
MYP,K?NQ*C]QF93QT08-<O"3MN/)M ':C+G4+0*B*&D*. [,LX:0,95 [!2B(
M*[V5"/%X;,]16G1Z0GPBGI[-7=, TUI0;,3S^'Z99E8'V67@1J]I-J=RS"NI
MO7'&SS0'5P3&_4 E;VH%J$F<_W4K"B6PP4_U2Y.01RCD[T$B?C(A$>\,$O&3
M"8DX(1$G).*$1#Q*(:<*MP\&>&%G*B@BVK*#>\]2GFB3M_6RVVF!66B91.\:
M/@'R?5_ 5%[5-&,;!H=H88\O4I9I-;V3C(NHRDHL=0?DC:(;&5$8*M.T!1;E
M"S9V%QK(;7VSEH-<!C)%;-9EKF!2LF\#1DH @SP]-*0S,[NX0@(2ES)9HZVG
M3(R%IOZ(\V1><KDL%DB31VQ,DO@_SUX!K6GB.68<@5I0F@:WZ'J:^G.]%2E+
M5KX*5 ?F,1$GJC)C^$]/^C8F/4'ZIU-T .&PK*4(B[?&=9K-C'.'GUMR.!UV
MN')#C''<;DR<%T"8;-+/?"4+T,LI11!";,Z% 6H\_;) 'UC6?1Y".PU5\,P*
MKP+8(*EW2W$3]S* G8Q?4D8,57AZ8'9]OM<"-I$09!5= 5P% D$=,"$XD(%.
M+&5+:#*OCK/LBGRT F=!T+QPJTJ66;'0&*E<NXM("I09?D\?E\'* >[L6@V&
MLJ"NDXVEB,>=+L:;I=FQ0QB.=NNT1=,#4:GPI\)#2\4R*TY3AB*D(+>(*>5U
M6 =!6N687+@V9D)D@G+]N;]R9<^%=?#RS%RR?1$>H &\.G0S<TWH!7:>O1Z%
M7U-(V,X*[/):ZV!Q_0SU??1PG:P/&Q9NI:14<022P<KIFE#:QY9OD<DSFF)%
ME0T]X#A PYJV?;F9PKNWFS2W?'G0JA%Y"+:7H<1V"/T,";<M0& R@6W?'D9$
M^1UU&^9=FP)JVER5"?5%TXMZ#.'CTY/1<C$4EVEL'Q3,7I>&:'S#-\_WU!MA
M'\UT^;GV.DILMRY*KSO#.OA!E0Y%V+*V^062]TF\5SENH[;4[:&;,,:SQS Q
MS:!XKF8W#)<6<#>!06?#!X3J5/0-@QAA'ZN.T?BVS$RKD;&#=S*=OXGX!K8B
M;.!)LIT":5^MUU^*G+LV3T>^4N_$=HJP3O4!#_!.H6%6R* @5)C6,-?AC+-S
M&.NC9^?%11%..(,NA5.5U2&N[9)3&[<'F'/8;82:+/MJ8:"I:V=#A_ O]R<I
M !+LOA[L;-QQZ0.H26^DA=/+T,<N8!?+NE;SHA/[$M\.'Z"5"/UGO)@F.O43
M/6_U"$3C$RT=U]>9UN4M"/FJ4KB9FH3 B[YSL&=:L2:AFU?0K@&T84L35O&P
M..7+8+<J2P1UIJK =8]4C3)LTU>V&[&AK)[P#-4[PEB7?4E9],I9%MFW:07@
ML %FN(N[Q%ECF.1DL)LF*\NJHZJ]W?8\NTC-X/<8:4K]/9!.*"6YF#@!R@A[
M9Q<B.J7H9>3Y] WES,'YL \&VF]8I7IOHNWU]/+)/N%NQ?A76=3UII>U]DS.
MW@9(Q0C]#8=T\OKFQ,!8C>A'S5DR !I:7UH\*^HDVL$#+P*G93A\2/*!&6D!
M)IT2$K=K;^W-VF 1F+\*-7PAAV9D,[IO:':9A6-,*(%49<".1-J+N'/H2[D\
M:9RD[4M]N26:'Q4O1N87?-QN9DSQP1A7O#H4,\QVV2H=)7>5)=5%?8\\]&F5
M3,BKHQ62QZ"Z]"]CXMAOMFN'L/3,B&-GA@5&;S5KZ]L,/+.Z\9!B5N[,4$,3
M7&F6WVRV/B_@I+9#'MEB64-%E?5V2,^UM)<#B3)AIT'/A]YM0YV/@>278?]U
M=>[V:"2G;3$VN&KP T+A9VB_$3'\@:Q'!J1U.Z5"XAL^>/(Q(RE@4PI1PA#F
MBK5@?&/:B 9-BW$Z2&/46>(>HE@@C298D"_>9W;@^ W1O[HZVS9^4\#.B";A
MS6,3"R'0ZSR1*76M>%+/"YJN'6N0"%K-<M<Y<=>ZUH*BR35B#HS>L*MACLQ&
M'S9H?X>3T^K7MXC)Q$,?@L+*HK A3JJJTXP)@MHPU/U6OT CD#YG,2\'L#BT
MQ[K8IH](V=R-RY.P+*Z*%NQ&?W=6'%ZCZ(^6EA@1<$+;GO1/S3B*9[Y\,O!H
M%&F^A1:RR"+1L#RK6V8J15I!,6<A&0.^@9SUL&S2.HY8Z<C-X2*7XO)U%]FV
M4<=FM#CBRAM/UU KPL@V#3#BC$,U#DVGI)1N" H[QA#2*+AY7]C9,S4>AWE(
M ]P#6 0'N<AH[LYRPO=/\+"C%?*O"!^=GYXH "F:D21ZGI;MU G@&(5\>[T3
M@)Z&YL)O#$+_G6OD['E3(YO :-.S;]^(?.+E:"'NU!M@$O*8A?P]^+M/)_S=
MG<'??3KA[R;\W82_F_!W1RFD&*PTG$Y/:#E-1NOM.EII?Y]9MNKW:=YJLX\F
M;:L1"Q)QR&V0V\G/L\1-"U$ZNFK#G0:^..T7=-9OY05?RO>^E0M^1H,@+;GQ
M^4Q<:==<SH8<8$HW$BE%1+_N8L@J1-P05A(#H4?SGQ!ER>;%:H54HQ)):OZ*
MZ0R+8?)'"(G9;UX\??GV^<7IB0[\4#K#ZO \MW L8J 5";*,>S[[Z$$B)AD[
M9OP-AZSUJPW)X7G3 8^7^T595 ,,[O']6?;D?C;?*I+P##*>L?$P"I5<V_8;
M;_5/%O&)!.7&$A)J6I4%3,<HY,9]V3*]BJ$(])E?19)VC)U'Z"H,G<55%?3$
MY L:$)^>8%HU]S)W.2<Y\CU9W^5MX<$I8P08-SZ7#"WD":JKJ4Q^2M8<K9!O
MT('L](2A_AT R$79C;B3+*<!1:2;L58< Q5&"F!#/B T*[,.X-?O1M!8%5B#
M&'1.^2]/3^9]OO(=-;5>A'OD!IB)S1_4LFFS?DO@VZIFBHDY&74NQ%VY\J7R
M9EJ%8 /XVDHKD^/G0S.#0-.$'/$&T7APZQ9 UC+"W6^M5O*@8WM3M)=M9.,<
M> )-#HK'5X#\_99P91DG,69ID*N8$1VT0[IH[SF&=MJ \C-<'=%%5DL*%&F>
MAZX+CJV:=73EMS(H5.:X>8NDU1_+_->^_H*@=!G[@!]1M9LFV *^UTA/<:F!
MMDU%6TX-B*<S&V_9DC368>G+B!7M5W]L^+@C7_]W8I,&1EPE@!E1XMJJ22<[
M9.NPAD9SQ'D)^XI3F;!@9(\_'MD?@3TI_-A:'Z+(> 9D!5)NQE:]LP-/[MY%
M$HH 95ZZQ= 6A'QF2QE")J2T8B$D6X-%HA9*L"66Q@/8Q3U&G%U4$RSI7=#0
M^HE\N'*!:!]B<0HU,R+D2E]<VPBE)&1+5P""TY+#T![<:D4U-)U<1KEQ+U9B
M;-AGB]FW0?^=GJ!-9).AI:*]V !*I*(A9E&9'>SE?+7&AJ'M5"2)O1J>=B0Z
MV_:1BS+)>+UZ VK(#IM.P:D@<0-$7"F$S5)"=YI>5&62G0RYT0 RIOUUY!O@
M3NS2GZBK@7<&(IG(/?$$$(()Z#2;=K5PPQX#XRS".>4R6+>8$;7D=\.RM6KV
MY*3"K/MWBX(MFKB)B71"M8(VZJ0L&R^6;$H=4W0A[:[,[M=7XGLI][A;BG_
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M%[$YM!Y2=B34]%?9<Y[0HQ!ITL8*^8%ZFW0K9ZLK$?+P-C^Y4' SA+K;K5^
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M-E[I?#O$*W!!,W '_#/[D/%.I%J'IM<L//6F&#C/!#W:[/[&E)+#$NA)T<M
M^G8W1G!HK"N59^B0=Y-"QU4K:.Y^.^WTV^ER:ECHI A7CZ654@%HBZ,QZ8LV
MAC>* *"?AE94[I @9E@:VND7.VX;6@:%8Q/KVARF94^8.0\:[M/&+VK9AU;Q
MFZUKA9)RH1<M>60W+=ZNM7[QI1(^6B>IL+P):CW<NR2K@P#*):5YMW!^CH'$
M Q^;91G"/6P#@PI+:60WFE(0W>BMOY[NRWV(Z9/@"MR.RG>#TS</IV2T#D;'
M6^/5'D//0,U$8"<AK2BJ8ENZO8I[0S^F:9=, ?\C%7) G]&V\^]D(2N1,U-N
M1R[]G1CBR6W^,$)^OP=M@>CI?NIJ/4$GCU-(!$V !Z@699_#A4M:GYZ)H7.F
M[0?$DF (^SQB#I2G4,R1O@GV1(Q0TV!39[!.*PZ5JV6?M"A&.1S;?C8><8+)
M$)GP1$<LY&"+S+*@B*85>XL [FO*Q5EOD5%!<*UA:);0!(["M6L\G#[X9!8#
M+)I8M)L/U<@&\_";;5GOO6\'CN#A=Z<GN<]%R!C:7J/U+:@$S[/OR==O<="T
M+AB$6^*W>G=5-[$EKA4:BQ$@DIGS;!'*T5>&(=%,(\BP/.HB0Q!3PS+(/V[E
MDFW# J+&4_62KS'4:,?>,"U&SL9C6J&W[X:P17@G3[>2<^4V)'^5H7M"G)^P
M>$W9LOL/"O&/_%WOQ(1,MN"'::V:F'$(5R':':S#T((J"[L ',T:5><N,,PY
M^U^W@4W6. MEC^!6>='*W2J_F#SW?QLA?P<6[*$\^Q4Q->V?L^] ?3E!P^X(
M-.SA_0D:-D'#[BXT[&X#L?[T]-7SG_^"?WSS]OOO_O+_ U!+ P04    " !L
M>65:VDOG1"H#  #="P  $0   ')D;G0M,C R-3 R,C<N>'-DM5;;<MHP$'WO
M3/]!]6O'-IB0"X%D.B1I:<AE(,FD3QUART1%EAQ)!O/WE7SC8G"!MCS)N^><
MW?7NRK0OXX" *>(",]HQZE;- (BZS,-TW#&>A^:78;?7,\#EQ<</0/W:GTP3
MW&!$O!:X8J[9HSX[!_<P0"WP%5'$H63\'+Q $FD+N\$$<=!E04B01,J11FJ!
MIN4T1\ T=]!]0=1C_'G0*W3?I Q%R[9GLYE%V13.&)\(RV7!;H)#"64D"K5:
M7,M^N]'OL' +\N=;%K*3>(!?QXB>1M>CU_#N 3Y<'\-'.6\VG>#'))X&@Z;O
MD]M?\]YD^.WX^WOW*'R,&\%X=-I+0[:%^X8""%0SJ.@8NKZLO%G#8GQL.[5:
MW7Z]ZP\3G)$"6S'!=+()7C\[.[,3;PXM(>,1)[ETP];N$12H4%9>7(''5$A(
MW16\)PO",KAII\X5*-X(/4ZA.(=Z: TGD&N-V=16#H5WCG)@),PQA&$!]J$8
M):*98P4LN"P#E7$=9,IYB,1&:.I:(0RN[I\*+(<>15)/I,8T:XYSHO:*H !1
M><-X<(5\&!&5QGL$"?8Q\@P@(1\CJ4=,A-!%E5KYE$)*F1IFM5&91=O"$*MI
M+0S*I+O;XHR@)Y4VT >U39L":)?=9>H^, #V.D9Z7)+*Q3SD8XJ3P-GNU(&I
M-R72):ICPFS;Z^"R4B20]T ODG/(D5#TI*"^,F3\#%+-=2%Q(W(0=9%?%3.S
MYZ^Q]'[S%1H@'R2KU])#TC$$UI>?D=G>./([!O>H-/-N_E1E6VJ(<HB.4+%Z
M28_6WU06.)> W"VIE*X&)<)"Q"56D[RT_VGJ6&KZXU(8H.,( ]C_L'("1_M6
MKBB(_,>2^UJ_7&O;7MTK];R^>VU5+N,2T-(*5]V?Z<W?9VXB54'13V;.,[7)
MK#MFHV[%PEMDND\2BS>P7Q(Y[X DMMSBF^*+;7!]T"-TM&O0+5^#RJ ;.38B
M4N26@U-8_G;\10Z)S%Y)K+33D]S6$EK4,54?&_7MZ?R)F3R+@X; 91&5?+[/
M("Q3\H?#NK'XZN_6B!R?-D'_$3@T[ %34 Z^:03:=JJFCK\!4$L#!!0    (
M &QY95HAR\EF_@H  ("&   5    <F1N="TR,#(U,#(R-U]L86(N>&ULS9U=
M;^.X%8;O"_0_L.Y-"XSCB=,MD.QD%QE/LC VFZ2Q9[;MHEC0$N,(H<F DA/[
MWY>41%FB>"0E14G.Q8Q'? _U4GQ,4E_'GW[<;2AZ(2)-.#L?'1]]'"'"(AXG
M;'T^^KH87RQF\_D(I1EF,::<D?,1XZ,??_CC'Y#\\^E/XS&Z2@B-S] 7'HWG
M[(%_CV[PAIRAGP@C F=<?(^^8;I56_A50HE ,[YYIB0CLJ#8\1GZ[FCZW0J-
MQP/J_498S,77^WE5[V.6/:=GD\GKZ^L1XR_XE8NG]"CBFV$5+C*<;=.JMH^[
MC^6?(OP33=C3F?IKA5."Y/%BZ=DN3<Y':K_E;E]/CKA83Z8?/QY/_OG+]2)Z
M)!L\3I@Z;A$9Z2A5BRWN^/3T=)*7:FE+N5L)JO=Q,M%VJIIE:=*AKSE)D[,T
MMW?-(YSEW=Z[&P0JU/_&6C96F\;'T_')\=$NC4?ZX.='4'!*[LD#RIMYENV?
M)4IIHD@8E=L>!7FPFZ%"3%3\A)$USDBL=G2J=G3\=[6C/Y>;K_&*T!%22LD'
MV*[31EUET,2UV3LB$AY?LO>Y-J,]V9??'9']#PVHQSMOPI)GF+[+?#W2N>T;
M\KXC?HAS?Z3E.$_>=Z1KD?\7VUG;\IL/K_VX4K7Q6GYJ6"2[3$Y@)-8F514=
M(W"^AWQB*.NN:N=1HUZJ1G,NVFU7,V->9TJBHS5_F<0DD75/_Z8^C-6'O-GR
M/[_/N%P)7*S23. HTS7ES3@?6<HGIB6EO!#:%Q913^-*Q23B<FIZSL:T.(Q%
M^(/@&^MNRU9S2^'O=%7%%X=%[@(PVI )DO*MB,B;>J7N%CI*I:,-E0JUI")L
M_'4Q^B'7H-^TZC^?)H=:''2T7 )M-X1E2UFCI07-8E?=;#.E>[E>%D0G6PR9
M?:PE2&D<=_"%W'&L=GY%\=IBWRAWU<566[J/&X5!=++-D=G+E08ID:]N_D+2
M2"3/:CG?U8Z&S'FG6TRV^KZF"0N!MC&8A)K6T\!^3]:)FEJ4!75^2]3&CF$,
MT+L>^CMMFW.!51P$-$,<@K-%/0A549XXNF!LB^D]>>:B"Y^FS#4U-I,F+'5-
M4(Q8C(%H%%I4B#T1\8^M/&,G@NY[H6@I77,!6#71,&1!T6'W!@)2R?TRLA28
MI8D:P'HA:4N=GVX 9ENG'H8N*$X <_ I2:7W2\KBD5"J[@=@UC^@V,2N:8$-
MF[RTE4$1 ]H#F<DC4!D2#C:7+VIU+I=) QM;T_N$IV6[BY]*'"Q"IL.!%.5A
M2,5Y(JEV&Z*'H9;2-3V 59,;0Q84,79O("N%'.5Z_Y!<LG@0(I7.#R"&33L>
MI2A .)K.^M"0:I]@7"5IA&GAY4IN2SN:9]&Z!@2T:T+2$@8%"N0.A*4(T,SD
M(5Z!^1?!8A@N-:4?6%I6[:A4L@!!,;WU8:+T7B"9;85HN(9G'%CJ[*9LC]GJ
M_BR@"P*4'G.MN[:%O &*IQGHDF5)ME?/T]UL-RLB+(UK2URQ 9G33)CE0;
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M)0>PV23&$ 5$BMT90$@E1H7:SPO:1?:(:I%5_.X0V$!([OAU[4[3QEO;5FU
MS'0:A-[A+G-^'-;&192G5RPSHGXO(GDA7W"&2V]@>R&YZY<JNTR;;U/:M $A
MU&D0?'^RBE&I8K!FREO*&#&32ZTU[WA*W%"Y3QS3LMC.'5-) L+#YJLC@XQ
M6NN%A<4&4_IYFR:,I/!$9*C<LF"UV&2A(0F(!9LO@(5<BK36"PN7&R+6<GK[
M2?#7[+',SPJV#5"[9:/3<I,1JS0@5KK\ <SH$%3$Z)2Z?N#9'1**%UD6X99:
MI(ZQ <T:S+1T(0$#F6O10DFDKK?<\ PM.?J:$I0]$G19_@Q=/1-\48^O7QJ)
M(O5"1+$J9S$6-H2ZQ,Y_=00TW/KMD98R")!Z[<&_0U)%(!WBF)I;R;"HG\?E
M)N89V8!O._2'N")HJ'G-49\^")H&FC29RL.:)]=Y(%*1/K,9U9/;PTN\ALCQ
MRMABT%@8UQ1!, +:@I;%]=\*\),[;[NB271%.8:OLC0TCC/FM>T9R?(.@H (
M:+N"4N3E0I0KO?3_9\R>Q/8YB_9W@D>$J*>LTFJTZKO^-C#:+3-O:E*3ID&A
M 7'V%K\ @8<J4*V.#[49R^?%//70N,KFQJ.GQ2.6!_!VFZ5J!I7&X*O@G4&.
M;R\,:(!QDZ$C(B#T!MB$;CCDD2@/_8"*8%2+]G1^EAZR )+X\_Z>/!"AWCM8
MDEWV6>[HJ>,,8T"LZ[.WP<TQ3^9Z X. \*UNH5.]%-4K0"OUC%A9!?I-58+R
M6FR_7U[?="T_R<UZD_QKA5,BM_P74$L#!!0    ( &QY95IPO>S]5@<  -%7
M   5    <F1N="TR,#(U,#(R-U]P<F4N>&ULS9Q=4]LX%(;O=V;_@S=['4)"
MV2X4M@,IZ61*"TMHN[LW'<56$@VRE)%DDOS[E>PXS8<E'VY\X *"\^KC?8XM
M^]B2+]XO4QX]4Z69%)>M[M%Q*Z(BE@D3T\O6UU'[:M0?#EN1-D0DA$M!+UM"
MMM[_]>LOD?VY^*W=C@:,\N0\^B#C]E!,Y+OH"TGI>?21"JJ(D>I=](WPS&V1
M \:IBOHRG7-JJ/VB:/@\.CWJG8ZC=AM0[S<J$JF^/@PW]<Z,F>OS3F>Q6!P)
M^4P64CWIHUBFL I'AIA,;VH[7AZO?XKB%YR)IW/W:TPTC2POH<^7FEVV7+OK
M9A<G1U)-.[WCXV[GG\^WHWA&4])FPG&+::LLY6JI*M<].SOKY-^6T@/E<JQX
MV<9)I^S.IF;[+0OHMWJBV;G.NW<K8V+RL-<V$WD5[K]V*6N[3>UNKWW2/5KJ
MI%7"SPDJR>D#G43NKXW>IE5%$D&-"U?'?=7I2[L[VG[FA6:*3BY;*A'&UMT[
M/>[UWKJ:?]\1F=7<[I::N;VJ%75V6ITKJJDPN=%;NV&G"%T:NS/1I*S(M0_K
MEV'&2=<[2C=JN[TJ2VU+]F.A7'>C[ B7\4[;W-&7>T;+/3EGK&E\-)7/G80R
MR[KWQGUP%-[D!.P_/_*&KL;:*!*;LB9.QI3G]?^PFCU)IX%>E20>;8W5G=I5
M[/=I.V17*HZD2JBRK,NZB(IW G6X4ZX5G3E1MJ)V/&-\$^.)DJF/SIJ$]'1T
M&Y1MHAF:5[;]Q/5AP,FT&N>>!,BSBP&TT@T6T0]4QXK-'9<:L#M*(-\>*M\*
M;PUC+H^=!SIEKK^N*^Y42]W&\+C@*0($?X(Y4@3=(D7@2HB,\ <ZEZH&_*X2
MR/L-)N\J;TB8_\Z(,E3Q%83T@1@(^Q03ML<A$N]'181FC@\$^*$:2/P/U L/
MCT<DY*,9Y=RE;T2 ]O(J/1#[6TSL?I^O /S-LSN_VU,+G/U6$2#^/U\+_@.W
M2!&XIXK)Q)[2%8#]@1A(_0R3NL<A*N\;D4!I;Z3@_ <?]IX])-0#IF/"BQX-
M[#8=QETAAR)'R3EK;:)B_Y<2!8:^)88B1TE#:RPV#+R?*;73F>"HXE=#D:,D
MH'4F&V9^(PPS*W>__TN6CG_>.-UE?:B",D9).GVF4-B6=QJ$<8\Q0GSWE5#&
M*+EFR!P*Y[[UHP@?BH0N/]%5"/2!%$H:)<<,VD-!?:]82M1JQ.+Z0>-0"X6-
MDEF&#:+0?B3+86)=L0DK'@360_<6@;)'22M!=E%",!2Q5'.Y=;NX+S-[/*[Z
M,@D.Z34%H>% R3=?8!TE*%=)8G'I]9];)F@W%(I*.?@9$5X  C9?"?;>R[#W
MX-A1\M!:FZ\$^\G+L)_ L:/DHK4V,;'W[<<[]2@7GB?07C$4.4HN6F,1$WA^
MIKE3]TH^LV(^5!WU@Q)0](@I:M@LZ@Y?G.0A>WNIA/)&3%>KS6%ROI?:$/X?
MF]==25;KH<P1$]>0T:9O,!9Q=S<M?%.)]B10OBBY:J6=II&Z""M*_+OOK@(*
M%"4!K3+3,,];Z9Y]S*0(WH\]5$&YHF22/E--#[QN&K'V'OI;7X-GL*$,J_LV
M&L;X73%C>]"7:9J)]3T:SU,QCQ2*%R7]"]IK&/5(<A8SP\3TL[U"5(SP:LY5
M.BADE&3/;ZQAPO>*NDA3>]F=S^-RZPS4W63B&WE#>BAQE%ROWB@N^:'6&54O
MY5]1"AH%E+0/:KKI<8;&F1WV5MW>^-&MF/&,,@<J*&N4E,]GJF&V7^2C(FZ=
MWFB5CB7W+P^I%$()HR1X 6L-0][I1S7>/0D4+$IF5VD':4RX6<8S(J;4/WNA
M6@D%C)+IA<RAC;U3T-@[?>'8BY+Q^4PAL2WFAMLCZF[,V93X5Y(%"X#7V6 2
M#UAM>OU>ON3'K>!6:=Z/@?U0C=TCA0+'62(9LM<TZBQAAB9%EP9,$!';E&JS
MKLV3G=>7@@8 9PTET#3*[?WOE/-/0B[$B!(M!4V*2_W0'7YO$6@4$)\AUMA%
M"<$WR3-+2>43097G&/!(H<@1GQUZ[.',O2PF-6_./<6K.D+$?26@X!$?(H;-
M(LU/,]3UF3W3#\20=0]#_'TEH/P1'RB&S:+-GU=]>^*9RO S\STAE#;B5-A*
M:RB01RGA_#K33% ='%OVA%#(B'->*ZVA0+Y)J9K:0>VCD@LS6Z_M#,'V%(!"
M1YS9&K2* W_Y<QUYL?XM2+Y"#7X[ 2)VKTFLUV[$L9M(49S)14*4AWI(#^6.
MNK#2;[1A\G=F1M7V]5/>F:'-VT*3'NI+0:. DJY"3>.<6[=6\@=/K3LZ*&_$
MQ+3*&,Z:J6S,63S@D@2ORW=D4+Z(66B%+12\UT0\J6QNXM6]DC&E[O&)WAQM
M@(0(6 $T)(CYZ8M0X-PND&GJ%A/)^&DTLZ;U76;R-Y?:_@5O&@3+04.#N8@3
M8!SI*DC_7.A%D^O5 YU0Y:8I/-*EN;8-/84OB@#%H?%!?:,0&$-%F"XZ![YN
M[0;W;MKB&_?+O7_5;OD?4$L! A0#%     @ ;'EE6@;I8(9\%   ?XX   T
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M,#(U,#(R-U]L86(N>&UL4$L! A0#%     @ ;'EE6G"][/U6!P  T5<  !4
M             ( !CN   ')D;G0M,C R-3 R,C=?<')E+GAM;%!+!08
.!@ & 'X!   7Z      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>radnet_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20250227.xsd" xlink:type="simple"/>
    <context id="AsOf2025-02-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2025-02-27</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-02-27" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-02-27" id="Fact000004">0000790526</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-02-27" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-02-27" id="Fact000010">2025-02-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-02-27" id="Fact000011">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-02-27" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-02-27" id="Fact000013">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-02-27" id="Fact000014">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-02-27" id="Fact000015">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-02-27" id="Fact000016">Los   Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-02-27" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-02-27" id="Fact000018">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-02-27" id="Fact000019">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-02-27" id="Fact000020">445-2800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-02-27" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-02-27" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-02-27" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-02-27" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-02-27" id="Fact000025">Common     Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-02-27" id="Fact000026">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-02-27" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-02-27" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
